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 Articular cartilage provides a low-friction surface during normal joint motion and 
distributes forces to the underlying bone. The extracellular matrix composition (ECM) of 
healthy cartilage has previously been shown to be an excellent predictor of its mechanical 
properties. Changes in ECM composition and loss of mechanical function are known to 
occur with degenerative conditions such as osteoarthritis. Identifying differences in the 
composition-function relationships of articular cartilage under different anabolic, 
catabolic, and homeostatic conditions may therefore be a useful approach for identifying 
factors (e.g. ECM content, distribution, and structure) which are critical to mechanical 
function. In addition, diagnostic tools capable of monitoring changes in the articular 
cartilage ECM may increase our understanding of the effects of ECM changes on 
composition-functions relationships.  
 The goals of this work were to investigate composition-function relationships in 
healthy, degraded, and engineered articular cartilage and to develop a µCT-based 
approach to analyze changes in matrix composition and morphology in articular cartilage. 
In healthy cartilage explants, compressive and shear properties were dependent on both 
sGAG and collagen content. In contrast, the compressive properties of IL-1-stimulated 
cartilage were dependent on sGAG but not collagen content. To assess changes in sGAG 
content, EPIC-µCT, a 3D contrast-enhanced microcomputed tomography technique was 
developed. EPIC-µCT attenuation was found to be an excellent predictor of sGAG 
content in IL-1-stimulated cartilage explants and engineered cartilage. In addition, 
analytical approaches were developed to use EPIC-µCT for the in situ analysis of 
 
xx 
cartilage morphology. EPIC-µCT was also used to analyze spatial differences in sGAG 
accumulation in bilayer engineered cartilage for comparison with the local strain profile. 
This work underscores the significance of ECM composition and structure in regulating 
cartilage mechanical properties and validates the use of EPIC-µCT as a diagnostic for 
monitoring sGAG content and potentially for assessing mechanical function in models of 









 Diarthroidal joints experience a complex combination of motion and mechanical 
forces during normal activity. The role of articular cartilage is to provide a low-friction 
surface during motion and to distribute forces to the underlying bone. The unique 
function of articular cartilage, in particular, is closely linked to its extracellular matrix 
(ECM) composition and organization1. Proteoglycans (PGs), collagen, and interstitial 
water within the ECM are regarded as the major regulators of articular cartilage 
mechanical function, with an osmotic swelling pressure generated by PG and water 
interactions and balanced by the collagen network providing resistance to applied loads. 
Supporting the role of the ECM in cartilage function, strong relationships have been 
reported between mechanical stiffness and proteoglycan and collagen content in healthy 
human articular cartilage2,3. Alterations in ECM composition and mechanical loading 
occur during development, in response to physical trauma, and during degenerative 
conditions including osteoarthritis (OA)4-9. Thus, the ability to noninvasively monitor 
changes in cartilage matrix composition, which may be reflective of changes in cartilage 
mechanical properties, could provide an alternate means of assessing function. 
Microcomputed tomography (µCT), a three-dimensional (3D) X-ray imaging technique, 
offers micron-level resolution, in vivo monitoring potential, and versatile spatial and 
morphological analysis but has seen little application in soft tissues due to their poor 
radiopacity. The development of a µCT-based approach for the monitoring of changes in 
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cartilage matrix composition would be useful both as a clinical diagnostic and as a 
research tool for improving our understanding of composition-function relationships in 
healthy, degraded, and engineered cartilage tissues.    
1.2 Research Objectives 
The overall goals of this work were to investigate composition-function 
relationships in healthy, degraded, and engineered articular cartilage and to develop a 
µCT-based approach to analyze changes in matrix composition and morphology in 
articular cartilage. Characterization of composition-function relationships in healthy, 
degraded, and engineered cartilage was of interest to identify any fundamental 
differences in the response of articular cartilage due to its local ECM composition. The 
development of a µCT-based approach for the analysis of cartilage ECM composition 
and morphology was designed to complement the composition-function investigations 
and to investigate its use as a surrogate for direct biochemical and mechanical 
assessment. Common to both pursuits was the goal of increasing our understanding and 
assessment of composition-function relationships in articular cartilage. Three specific 
aims were designed to investigate the research objectives, using both a model of cartilage 
degeneration and tissue engineering strategies.   
   
SPECIFIC AIM I: Characterize the composition-function relationships of healthy and 
degraded articular cartilage using interleukin-1 (IL-1) stimulation to induce cell-mediated 
degradation.  
 To investigate the composition-function relationships of healthy and degraded 
articular cartilage, articular cartilage explants were cultured in either control or IL-1-
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supplemented media for up to 32 days. At regular intervals, matrix composition and 
mechanical properties of both treatments were characterized. Sulfated glycosaminoglycan 
(sGAG) and collagen contents in both the media and explants were assessed by 
biochemical assays. The complex shear modulus and the equilibrium and dynamic 
unconfined compression moduli were measured by mechanical testing at corresponding 
time points. Correlation and linear regression analyses were performed to determine 
relationships among ECM components, among mechanical properties, and between ECM 
components and mechanical properties. 
 
HYPOTHESIS I: IL-1-stimulated degradation of articular cartilage will alter the 
composition-function relationships reported for healthy articular cartilage. Specifically, 
composition-function relationships in degraded articular cartilage will be more dependent 
on sGAG content than in healthy articular cartilage. 
 
SPECIFIC AIM II: Develop and validate a µCT-based technique for the imaging of ECM 
composition and morphology in articular cartilage.  
 The approach taken in developing the µCT imaging technique was to use an ionic 
contrast agent to increase the radiopacity of the cartilage matrix while exploiting the 
interaction with the negative fixed charge density (FCD) primarily associated with the 
sGAGs attached to PGs within the ECM. With its reliance on the Equilibrium 
Partitioning of an Ionic Contrast agent to relate differences in FCD, the technique was 
dubbed EPIC-µCT. Initial work focused on the selection of a contrast agent with a high 
X-ray attenuation signal and an osmolality similar to that of cartilage, as well as 
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characterization of the time needed to reach chemical equilibrium within cartilage 
explants. Subsequent studies examined the relationship between EPIC-µCT X-ray 
attenuation and sGAG content in control and IL-1-stimulated cartilage explants. 
Additional studies developed approaches to isolating cartilage from surrounding tissues 
in situ in an intact rabbit joint.  
 
HYPOTHESIS II: The X-ray attenuation of articular cartilage equilibrated in a 
negatively-charged, radiopaque contrast agent will be inversely correlated with its sGAG 
content, providing a nondestructive and accurate predictor of sGAG content. 
 
SPECIFIC AIM III: Explore the use of EPIC-µCT in monitoring sGAG accumulation in 
tissue engineered constructs and characterize the composition-function relationships of 
tissue engineered constructs. 
Two studies were conducted using 3% agarose gels seeded with either articular 
chondrocytes (AC) or a co-culture of AC and meniscal fibrochondrocytes (MFC). The 
first study examined the effects of the EPIC-µCT protocol (e.g. contrast agent exposure, 
X-ray scanning, both) on matrix composition, proliferation, and cell viability at regular 
intervals during development in longitudinally-monitored constructs. A second study was 
conducted to monitor the temporal and spatial development of a bilayer agarose construct 
using both EPIC-µCT and two-dimensional (2D) strain microscopy (in collaboration with 




HYPOTHESIS IIIa: Repeated application of the EPIC-µCT protocol will not negatively 
affect cell viability or sGAG production in tissue engineered cartilage constructs and will 
be sensitive enough to quantify sGAG accumulation during construct development. 
 
HYPOTHESIS IIIb: EPIC-µCT will be sensitive to spatial patterns of sGAG 
accumulation in constructs and a strong indicator of the mechanical properties in tissue-
engineered constructs. 
1.3 Significance and Contribution 
 The studies performed reveal differences in composition-function relationships in 
healthy, degraded, and engineered articular cartilage and validate EPIC-µCT as a novel, 
noninvasive 3D imaging technique for the assessment of articular cartilage composition 
and morphology. The use of IL-1 to stimulate degradation in cartilage explants provided 
insights into the altered composition-function relationships that occur during 
degenerative conditions. This information may be useful in developing interventional 
strategies aimed at reversing or halting degradation in vivo. The development of EPIC-
µCT represents a promising contribution to the area of cartilage diagnostics. The 
technique’s ability to accurately monitor changes in sGAG content in cartilage explants, 
intact joints, and engineered constructs illustrates its sensitivity over a wide range of 
sGAG contents and its ability to isolate and analyze distinct spatial regions of interest. 
The initial investigations into the ability of EPIC-µCT sGAG measurements to predict 
mechanical properties suggests the technique may be a useful surrogate to mechanical 
testing in assessing the function of articular cartilage. Finally, the spatial resolution of 
EPIC-µCT makes the technique particularly attractive for studying matrix changes in 
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small animal models of degeneration and regeneration, where the limited thickness of 
articular cartilage prohibits accurate assessment of composition and direct measurement 






2.1 Articular Cartilage 
2.1.1 Composition and Organization 
Articular cartilage is a type of hyaline cartilage that lines the bony surfaces of 
diarthrodial joints (Figure 2.1). While its primary function lies in lubrication, articular 
cartilage also plays a role in load distribution and shock absorption. The functionality of 
articular cartilage arises from a complex ECM that is secreted and remodeled by 
entrapped chondrocytes and is characterized by a heterogeneous, zonal organization of 
type II collagen, proteoglycans, and water1,10-12. 
 
 
Figure 2.1: Color photographs of a dissected 1-2 week-old bovine femur. Articular 





The molecular structure and organization of the matrix constituents of articular 
cartilage contribute to its range of properties. Type II collagen, a fibrillar protein that 
carries a nearly neutral charge, represents 10-20% of the wet mass and provides the 
primary tensile strength and tensile stiffness. PGs comprise 5-10% of articular cartilage 
by wet mass and consist of a varying number and type of negatively-charged sGAG 
chains covalently attached to a core protein. The large aggregating PG aggrecan 
represents 50-85% of the total PG content and has up to 50 keratin sulfate and 100 
chondroitin sulfate side chains (Figure 2.2). Interactions between sGAGs and ionic 
interstitial fluid create an osmotic swelling pressure that is balanced by fibers in the 
surrounding collagen network, offering resistance to applied loading.  
Cartilage is often divided into distinct zones, as the organization of collagen, PGs 
and water varies significantly throughout the depth of the tissue (Figure 2.3). The 
superficial zone (10-20% of total thickness) is characterized by the lowest PG density and 
flattened chondrocytes interspersed in a dense network of collagen fibers that run parallel 
to the articular surface. In the middle zone (40-60%), the chondrocytes have a more 
spherical morphology, the collagen density decreases, the PG density reaches a 
maximum, and the collagen fibers appear randomly oriented about a preferred 45° angle. 
In the deep zone (lower 30%), collagen fibers are oriented perpendicular to the 
subchondral bone and cell density is at its lowest. Water content is highest in the 
superficial zone and begins a gradual decrease with depth in the middle zone1,12,13. 
Mature tissue has been shown to exhibit a significantly higher collagen fiber and collagen 






Figure 2.2: The molecular representation of the PG aggrecan, illustrating the location of 
keratin sulfate (KS) and chondroitin sulfate (CS) side chains relative to the three globular 
domains (G1, G2, G3) on the aggrecan core protein. Aggrecan associates with hyaluronic 




Figure 2.3: The relative distribution of ECM water, PGs, and type II collagen throughout 
the depth of articular cartilage (SZ=superficial zone, MZ=middle zone, DZ=deep zone). 




2.1.2 Mechanical Properties 
The mechanical properties of articular cartilage have been extensively 
characterized and have been shown to vary with species1,3,18, loading mode1,19,20, disease 
state6,13,21, age22-25, topographical location18,26,27, and depth within the tissue20,25,26,28. 
Commonly reported values of tissue moduli for healthy bovine articular cartilage are 
presented in Table 2.1. The aggregate and unconfined compression moduli are measured 
by application of a compressive displacement through a rigid platen and provide an 
indication of the equilibrium stiffness of the tissue with or without radial confinement, 
respectively. As the aggregate modulus restricts lateral expansion of the collagen 
network, the measurement characterizes primarily the interactions of the negatively-
charged PGs and interstitial fluid. By allowing lateral expansion of the collagen network, 
the unconfined compressive modulus evaluates the contribution of the collagen network 
as well as PG-fluid interactions. The dynamic compressive modulus is frequency and 
offset dependent, with higher loading frequencies and compressive offsets producing a 
stronger resistance to deformation. The shear modulus, which reflects the resistance to 
distortion in the absence of volumetric changes, is also offset dependent and may be 
measured under equilibrium or dynamic conditions.  
2.1.3 Composition-Function Relationships 
 Additional studies have examined composition-function relationships in fetal9,29, 
immature9,29, mature20,29, and tissue-engineered30 cartilage under either compressive, 
tensile or shear loading conditions. In general, the mechanical properties of healthy 




Table 2.1: Mechanical properties of bovine articular cartilage compiled from references 
4,20,26. Dynamic compression modulus is reported for 3mm diameter full thickness 
explants tested in unconfined compression at 10% strain and a rate of 2mm/s.  Dynamic 
shear modulus is reported for 0.01-20Hz at 5-16% compressive strain. 
 
Mechanical Property MPa 
Equilibrium Tensile Modulus 4-7.79 
Compression Moduli  
– Aggregate (Confined) 0.47-0.89 
– Unconfined 0.2-5.5 
– Dynamic (magnitude) 5.0-16.0 





2.2 Articular Cartilage Pathology 
2.2.1 Osteoarthritis 
 OA generally refers to a set or subset of clinical symptoms associated with the 
degeneration of articular cartilage, including patient pain, joint space narrowing by 
conventional X-ray or MRI, and joint instability. Pathologically, OA is characterized by 
loss of PGs, fibrillation and fissuring of the articular surface, decreases in modulus and 
ultimate tensile strength and elevated levels of matrix-degrading enzymes including 
aggrecanases and matrix metalloproteinases (MMPs)1,4,13,31. The precise etiology of OA 
is poorly understood but its incidence is increased with aging and it may be accelerated 
by mechanical trauma. The problem is compounded by the poor repair capacity of mature 
articular cartilage. Current OA treatments are focused on preserving existing cartilage 
function and managing patient pain. Clinical interventions include drug treatments to 
inhibit matrix enzyme activity, osteochondral transplantation, debridement, and in 
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extreme cases, total joint replacement. These treatments are met with varied success, 
suggesting that a better understanding of cartilage biology and OA development is 
needed to improve patient outcomes. 
2.2.2 Aging 
In addition to the reduced capacity for self-repair that accompanies tissue 
maturation, a number of changes occur in the ECM composition and organization of 
cartilage. The accumulation of non-enzymatic glycation products with age has been 
shown to increase collagen network stiffness, potentially making it more brittle and 
susceptible to fatigue-induced damage32. In addition, changes in the sulfation patterns of 
sGAGs have been reported15, which may alter the osmotic swelling properties of the 
tissue. Cell metabolic activity has also been shown to vary with age, with mature 
chondrocytes synthesizing less collagen and PGs of smaller size and shorter sGAGs5. 
Age-related differences in the response of cells to growth factors have also been 
observed33,34. 
2.2.3 Mechanical Injury 
 Meniscectomies and anterior cruciate ligament transections have resulted in 
decreased ECM content, altered ECM organization and decreased mechanical properties 
of articular cartilage in canine models6,35. Models examining blunt trauma to the knee 
(e.g. automobile accident) have also indicated softening and fissuring of articular 
cartilage36,37. Mechanical injury models have been shown to decrease matrix synthesis38-
40 and elevate MMP levels41, in addition to causing physical disruption of the matrix39-42. 




2.3 Effects of Cytokines on Articular Cartilage 
2.3.1 Degradation Models  
To study the development and progression of OA and to characterize events 
following articular cartilage injury and their relationship to OA, a variety of models have 
been developed. Among the biochemical stimulation models, the most commonly cited 
are the in vivo introduction of fibronectin45-48, in vitro stimulation of chondrocyte-
mediated catabolism using factors such as retinoic acid49-51, tissue necrosis factor-α52,53 or 
IL-149,52,53, and direct ECM digestion via addition of exogenous proteolytic enzymes20,54. 
IL-1α and IL-1β have received particular focus both in vitro and in vivo as 
regulatory and inflammatory cytokines implicated in the progression of OA. Within hours 
of exposure to exogenous IL-1, upregulation in transcription and activation of 
aggrecanases occurs in monolayer cultures of chondrocytes and tissue explants, leading 
to early breakdown and release of PGs21,49,53.  Following degradation of the PGs, 
activation of MMPs leads to enzyme-mediated degradation of the collagen network21,49,55. 
Furthermore, IL-1 induced degradation is dose-dependent56-59 and IL-1 exposure has also 
been shown to decrease sGAG49,57,59,60 and protein synthesis49,58,61,62.  Depletion of PGs 
and collagen network degradation are accompanied by increases in osmotic swelling and 
permeability and decreases in equilibrium and dynamic compressive moduli and 
compression-induced streaming potential21,49. 
2.3.2 Stimulation Models 
 Anabolic cytokines or growth factors have been shown to be potent stimulators of 
ECM synthesis. In particular, transforming growth factor-β (TGF-β) has been shown to 
stimulate PG synthesis up to seven times over untreated, serum-free bovine articular 
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cartilage explants. This stimulation appears to be dose-dependent, with maximal PG 
synthesis in explant culture achieved at a concentration of 10ng/mL63. TGF-β has also 
been shown to stimulate protein synthesis over 0.1-10ng/mL in primary rabbit articular 
chondrocytes64. TGF-β has exhibited stimulatory effects in the recovery of PG synthesis 
following IL-1 treatment of articular cartilage explants65,66. The stimulatory effect of 
TGF-β on PG synthesis appears to decline with age in both human and bovine articular 
cartilage33,34.   
2.4 Imaging Techniques 
2.4.1 Cartilage-specific 
 Several nondestructive imaging techniques have been used to examine the 
composition and structure of cartilage and surrounding tissues, with the spatial resolution 
of the imaging application often dictating the technique used. Traditional x-ray and 
computed tomography (CT) are commonly used in evaluating joint space narrowing and 
changes in the adjacent bone structure (e.g. osteophytes). Unaided magnetic resonance 
imaging (MRI) extends these capabilities to the 3D visualization of fissures and tears of 
the articular surface67. The emergence of contrast-based MRI techniques including 
delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) have provided accurate, 3D 
regional profiles of sGAG concentration in both developing and degrading matrices56,68. 
Similarly, optical coherence tomography (OCT), a light-based technique analogous to the 
application of sound waves in ultrasound, has shown promise in monitoring the fibrillar 
organization of collagen in normal and osteoarthritic cartilage69,70. Fourier Transform 
Infrared Imaging Spectroscopy (FT-IRIS) has been shown to detect changes in sGAG 
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content and collagen content and fiber orientation by monitoring changes in frequency 
absorbance spectrums71. 
2.4.2 Microcomputed Tomography 
 As with conventional CT, µCT has been widely used in the imaging of bone and 
is the standard method for quantifying trabecular bone architecture72-76. The high spatial 
resolution, fast scan times, quantitative morphology analysis, and 3D reconstruction 
capabilities provided by µCT have recently led investigators to explore its potential in 
non-traditional applications such as the characterization of porous biomaterials and soft 
tissues. For example, the use of a perfused contrast agent with µCT has provided 
quantitative analysis of the 3D morphology of vascular networks77. µCT has not 
generally been used to analyze cartilaginous tissues due to the inability of soft tissues to 
attenuate x-rays, but a recent study using the paramagnetic probe Gd-DTPA2- 




ALTERED COMPOSITION-FUNCTION RELATIONSHIPS IN 




 Articular cartilage, a hyaline cartilage that lines the bony surfaces of diarthrodial 
joints, provides joint lubrication and load distribution to the underlying bone. The tissue 
is comprised of chondrocytes embedded within a dense ECM consisting primarily of the 
large, aggregating PG aggrecan, type II collagen, and water. The high density of 
negatively-charged sGAG chains attached to the aggrecan core protein gives rise to an 
osmotic swelling pressure that resists compression and is balanced by tensile stresses 
carried by the collagen fiber network.  Due to low tissue permeability, dynamic loads 
produced by functional activity are carried primarily through pressurization of entrapped 
fluid79.  The resident chondrocytes synthesize and remodel the ECM1,12,80,81 but can also 
contribute to tissue destruction in various degenerative conditions.  
Relationships between ECM composition and mechanical properties have been 
studied to elucidate the contributions of PGs and collagen to macroscopic mechanical 
behaviors in healthy, developing and degenerating articular cartilage2,4,9,29-31,82. Previous 
studies have probed collagen network integrity by characterizing swelling-induced 
changes in geometry or stress created by hypotonic conditions49,83,84. Explant stiffness 
arising from the interactions of the PGs and collagen network under both cyclic and 
steady-state loads have been extensively characterized by the dynamic and equilibrium 
moduli in compression, shear and tension20,26,85,86. Indentation studies, performed either 
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in vitro or in situ, provide yet another assessment of the composition-function 
relationships present in articular cartilage87,88.        
Characterizing the composition-function relationships of articular cartilage during 
degeneration may elucidate the contributions of matrix constituents to altered cartilage 
function. As the regulatory and inflammatory cytokine IL-1 has been implicated in the 
progression of OA, stimulation of articular cartilage with IL-1 provides an appropriate 
model for investigating these relationships. Within hours of exposure to exogenous IL-1, 
upregulation in transcription and activation of aggrecanases occurs in monolayer cultures 
of chondrocytes and tissue explants, leading to early breakdown and release of PGs21,49,53.  
Following release of the PGs, the collagen network in cartilage explants undergoes 
MMP-mediated degradation21,49,55. Furthermore, IL-1-induced degradation is dose-
dependent56-59 and IL-1 exposure has also been shown to decrease sGAG49,57,59,60 and 
protein synthesis49,58,61,62.  Depletion of PGs and collagen network degradation are 
accompanied by increases in permeability and decreases in equilibrium and dynamic 
compressive moduli and compression-induced streaming potential21,49.   
The cell-mediated destruction of PGs and collagen and loss of mechanical 
properties that are observed with IL-1 stimulation suggest the utility of this model in 
examining composition-function relationships in degenerating articular cartilage. To that 
end, this study presents a detailed time course of the biochemical and biophysical 
changes associated with IL-1-stimulated cartilage degradation and then examines the 
relationships between biochemical composition and functional properties. In addition to 
furthering our understanding of the importance of PGs and collagen to normal 
mechanical function, this study also contributes to our knowledge of cartilage 
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degeneration by identifying changes in composition-function relationships associated 
with IL-1-mediated catabolism.  
3.2 Materials and Methods 
3.2.1 Tissue Explant Preparation and Culture 
Under aseptic conditions, 3mm diameter full thickness cartilage explants were 
harvested with a dermal biopsy punch (Miltex; York, PA) from the femoral condyles and 
patellar grooves of both stifle joints of a 1-2 week old bovine calf (Research 87; 
Boylston, MA). A custom cutting block was used to remove the most superficial ~300µm 
and the deep zone tissue, resulting in middle zone explants with a thickness of 1.78 ± 
0.020mm as measured with digital calipers (Mitutoyo USA; Aurora, IL). Forty explants 
were randomly assigned to either control or IL-1 stimulation. To allow for equilibration 
to culture conditions, explants were precultured for 72 hours at 37°C and 5% CO2 in 
serum-free control medium consisting of high glucose Dulbecco’s Modified Eagle’s 
Medium (DMEM) supplemented with 50µg/mL gentamicin, 0.1mM non-essential amino 
acids (Invitrogen; Carlsbad, CA) and 50µg/mL ascorbate (Sigma; St. Louis, MO). 
Explants were placed two per well in 48 well plates (Becton Dickinson; Franklin Lakes, 
NJ) in 0.5mL of either control medium or control medium supplemented with 20ng/mL 
recombinant human IL-1α (Peprotech; Rocky Hill, NJ). This IL-1 dosage has previously 
been shown to induce aggressive cell-mediated degradation, with complete depletion of 
sGAGs within two weeks21,89. Samples were cultured for up to 32 additional days, with 
media changed and collected every 48 hours. Four explants per group were removed from 
culture at 4, 8, 12, 16, 24, and 32 days following pre culture and stored in 0.15M PBS 
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(Invitrogen) with protease inhibitors (PI Cocktail Set I, Calbiochem; San Diego, CA) at -
20°C for subsequent compression testing and biochemical analysis. 
A second degradation study was conducted specifically to examine changes in 
shear properties due to IL-1 stimulation. Sixty-five explants (4mm diameter x 2mm thick) 
were isolated as described above from middle zone cartilage of a second 1-2 week old 
calf. Following a 3-day preculture, explants were cultured in individual wells for up to 24 
additional days in 0.5mL of control medium or control medium supplemented with 
20ng/mL IL-1α. Five explants per group were removed from culture at days 0, 4, 8, 12, 
16, 20, and 24 and stored in 0.15M PBS with protease inhibitors at -20°C for subsequent 
dynamic shear testing and biochemical analysis.    
 3.2.2 Mechanical Testing 
Prior to mechanical testing, explants were thawed at room temperature. 
Thicknesses were measured with digital calipers and wet masses were also determined. 
Compression testing of tissue explants was performed using a SMT-S 5.6lbf load cell 
(Interface; Scottsdale, AZ) and an ELF 3230 testing frame (Enduratec; Minnetonka, MN) 
at room temperature in 0.15M PBS with protease inhibitors, with displacements corrected 
for load cell compliance. Torsional shear testing was performed using a CVO 120HR 
stress-controlled rheometer with strain feedback (Bohlin; East Brunswick, NJ). 
Samples were tested in unconfined compression by applying a 0.1N tare load 
followed by four steps (5% each, 1mm/s ramp rate) of stress relaxation with a 10 minute 
relaxation after each strain step. As 10 minutes may not reflect complete relaxation, the 
force vs. time data, F(t), for each step were fit to an analytical solution for the unconfined 
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∞                                                                  3.1 
where F∞ is the equilibrium (relaxed) force, 
2 2
n nA 1/ (1 ) α (1 2 ) υ υ = − − −  , αn are the 
roots to the characteristic Bessel function equation ,0)21/()()1()(1 =−−− νν xJxxJ o a 
is the sample radius, HA is the aggregate modulus and k is the linear permeability.  For 
each relaxation step, a three parameter least squares fit was performed using Matlab 7.1 
(Mathworks; Natick, MA) to determine the value of the step offset, F∞, and the product 
HAk assuming a Poisson’s ratio of 0.1 and using the first five terms of the analytical 
solution.  A linear regression of the equilibrium stresses (F∞/(πa
2)) against the applied 
strain over the range of 10-20%  was used to determine Eequil, the unconfined 
compression equilibrium modulus of each sample.    
After relaxation at the 10% compression step, sinusoidal compression (±1.5% 
strain) was applied at 0.005, 0.05, 0.5, and 5Hz. For each frequency, the magnitude of the 
dynamic compressive modulus, |E*dyn|, was calculated by WinTest DMA software 
(Enduratec) as the ratio of the fundamental stress and strain magnitudes determined using 
a Fast Fourier Transform.  
Samples were tested in torsional shear by applying a 10% compressive offset and, 
after a 12 minute relaxation, applying a nominal sinusoidal shear strain of 0.5% 
amplitude over a range of frequencies (0.01, 0.1, 1, and 10Hz). The magnitude of the 
complex shear modulus |G*dyn| was determined by the rheometer software from the ratio 
of the measured stress to the applied strain.   
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3.2.3 Biochemical Analysis 
Following mechanical testing, explants were lyophilized overnight and dry 
masses were determined. Explants were then solubilized with 4 mg/mL proteinase K 
(Calbiochem) in 100mM ammonium acetate (pH 7.0) (Sigma). The digested explants and 
conditioned media were assayed for sGAGs via the dimethylmethylene blue (DMMB)  
assay90, using shark chondroitin sulfate (Calbiochem) as a standard. Collagen was 
assayed via the pDAB/chloramine-T assay for hydroxyproline, using trans-4-hydroxy-L-
proline (Sigma) as a standard  and assuming a 1:8 mass ratio of 
hydroxyproline:collagen91.  As the compressive properties were expected to be related to 
the matrix fixed charge density (FCD, or charge per unit interstitial fluid volume), the 
sGAG and (for consistency) collagen contents were normalized by water volume in the 
composition-function analyses. 
3.2.4 Statistical Analyses 
All statistical analyses were performed using Minitab Release 14 (Minitab; State 
College, PA) with significance at p<0.05.  Interdependence among matrix components or 
among mechanical properties was determined via linear correlation analyses.  Differences 
among time points in a given treatment group or between treatments at a given time point 
were examined via one-way ANOVA with Tukey’s test for posthoc pairwise 
comparisons. To compensate for heteroscedasticity, the equilibrium modulus and 
dynamic shear modulus data were log transformed prior to ANOVA. Due to loss of 
sample integrity for IL-1 treated explants, sample sizes were insufficient to perform some 
comparisons at later time points. Regressions of mechanical parameters against matrix 
constituents were compared between treatment groups as described by Zar92 using 
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custom Minitab macros. Briefly, the groups were first compared to test the null 
hypothesis of equal regression slopes. In the case of a common slope, the groups were 
then compared to test the null hypothesis of equal intercepts. A common regression was 
used if neither null hypothesis was rejected. 
3.3 Results 
3.3.1 Explant and Media Biochemistry 
As previously demonstrated21,49,53,55,93,94, treatment with 20ng/mL IL-1α resulted 
in substantial matrix depletion over the 32 day culture period. sGAG release for IL-1-
stimulated samples peaked at day 8 with 59% of total sGAG released (Figure 3.1A) and 
was essentially complete by day 14. Collagen release to the media by IL-1 samples 
became significantly elevated over controls at day 6 (p<0.05), peaked near day 14, and 
remained essentially constant through day 24, at which point 74% of the total collagen 
release had occurred (Figure 3.1B). Control samples displayed a steady increase in sGAG 
content over the culture period, indicating a basal level of proteoglycan synthesis (Figure 
3.2A). Consistent with the sGAG release data, the residual sGAG content of IL-1-
stimulated explants decreased relative to control explants during the first 16 days in 
culture and reached the detection limit of the DMMB assay by day 24. The residual 
collagen content of control explants did not significantly vary during the culture period, 
while the collagen content of the IL-1-stimulated explants gradually decreased following 
day 8 (Figure 3.2B).  Explant water content showed little variation with culture in either 
control or IL-1 groups (Figure 3.2C). A steady increase in the thickness of control 
explants accompanied the increased sGAG, with no further increase for the duration of 
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culture (Figure 3.2D). In contrast, the thickness of IL-1 treated explants did not 




Figure 3.1: sGAG (A) and collagen (B) release to the media over 48 hour period for 
control (●) and IL-1 treated (○) explants. * denotes p<0.05 between control and IL-1-




3.3.2 Explant Mechanical Properties 
ANOVA indicated no significant effect of culture time on the control equilibrium 
modulus (p=0.076) or dynamic modulus (p=0.063) (Figures 3.3A-3B).  In contrast, IL-1-
stimulated explants exhibited substantial changes in mechanical properties reflecting the 
ECM degradation kinetics.  Both the equilibrium modulus and dynamic compression 
modulus decreased as the sGAG release progressed, with the equilibrium modulus 
reaching detection limits by day 16.  The dynamic modulus remained measurable through 
day 24, indicating sensitivity to relatively small levels of residual matrix.  Treatment with 
IL-1 for 32 days resulted in sufficient matrix loss that explants could not sustain handling 
for mechanical testing.  The dynamic compressive modulus exhibited similar frequency 
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dependence across time points and treatment groups, with consistent differences between 






Figure 3.2: Residual sGAG content (A), collagen content (B), water content (C), and 
explant thickness (D) as a function of culture time for control (●) and IL-1-stimulated (○) 








Figure 3.3: Compressive and shear properties as a function of culture time for control (●) 
and IL-1-stimulated (○) explants: (A) Equilibrium unconfined compression modulus; (B) 
Dynamic unconfined compression modulus at 0.5Hz; (C) Dynamic shear modulus at 
1Hz. * denotes p<0.05 and † denotes p=0.06 between control and IL-1-stimulated 
explants (n=4-5, mean±SEM). Ø denotes an insufficient number (n≤2) of IL-1-stimulated 
explants to perform the statistical analysis. 
 
 
ANOVA indicated that the dynamic shear modulus of control explants did not 
vary with culture time (p=0.130) (Figure 3.3C).  In contrast, the dynamic shear modulus 
of IL-1-stimulated explants exhibited an initial rapid decrease through day 8 and 
continued to decrease until it reached detection limits at day 20.  The dynamic shear 
modulus appeared to stabilize in the period between peak sGAG release and substantial 
collagen release (days 8 and 12), suggesting that |G*dyn| is sensitive to changes in both 
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sGAG and collagen content. As with the dynamic compression modulus, the dynamic 
shear modulus exhibited similar frequency dependence across time points and treatment 







Figure 3.4: Dynamic unconfined compression modulus as a function of frequency and 








Figure 3.5: Dynamic shear modulus as a function of frequency and culture time for 
control (A) and IL-1-stimulated (B) explants (n=4, mean±SEM). 
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3.3.3 Composition-Function Relationships 
 Regression analyses indicated substantial differences between control and IL-1- 
simulated explants in the dependence of mechanical properties on tissue composition   
(Table 3.1). The dependence of Eequil on sGAG concentration was not significantly 
different for control and IL-1-stimulated explants, but the regressions were significantly 
different between treatment groups for all other mechanical properties. The compressive 
properties of control explants were significantly dependent on sGAG concentration 
(Figures 3.6A-3.6B) and collagen concentration (Figures 3.6D-3.6E). In contrast, for IL-
1-stimulated explants, all compressive properties were strongly dependent on sGAG 
concentration (Figures 3.6A-3.6B) but none were significantly dependent on collagen 
concentration (Figures 3.6D-6E). Both for control and IL-1-stimulated explants, |G*dyn| 
was strongly dependent on sGAG concentration (Figure 3.6C) and weakly dependent on 
collagen concentration (Figure 3.6F).  Note that the regression analyses of the unconfined 
dynamic compression modulus |E*dyn| and dynamic shear modulus |G*dyn| are reported for  
data obtained at 0.5Hz and 1.0Hz, respectively, although the trends remained consistent 










Table 3.1: Linear regressions of physical properties as a function of biochemical 
composition in control and IL-1-stimulated explants. Linear regression coefficients are 
significant at p<0.05 (NS=non-significant). Common regression coefficients are indicated 
by a box that spans the two groups. Units of all mechanical properties are in MPa (Eequil = 
Equilibrium Unconfined Compression Modulus, |E*dyn| = Magnitude of Dynamic 
Compression Modulus at 0.5Hz, |G*dyn| = Magnitude of Dynamic Shear Modulus at 
1Hz).  
 
y = a*x + b 
x = sGAG /H2O (mg/mL) x = Collagen /H2O (mg/mL) 
y 
 R2 A b R2 a b 
Control 0.48 6.19E-03 5.54E-03 
Eequil 
IL-1 treated 
0.66 9.03E-03 -5.76E-02 
NS -- -- 
Control 0.27 6.88E-02 6.47E+00 0.51 5.77E-02 6.03E+00 
|E*dyn| 
IL-1 treated 0.96 1.53E-01 -3.12E-01 NS -- -- 












Table 3.2: Correlations between biochemical constituents for control and IL-1-stimulated 





collagen/H2O sGAG/H2O collagen/H2O sGAG/H2O 
sGAG/H2O +0.780  NS  






Figure 3.6: Physical properties plotted against sGAG concentration (A-C) and collagen 
concentration (D-F) for control (●) and IL-1-stimulated (○) explants. Data are presented 
on logarithmic scales. 
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Table 3.3: Correlations between compressive properties of control and IL-1-stimulated 
explants. Correlation coefficients are significant at p<0.05 (Eequil = Equilibrium 
Unconfined Compression Modulus, |E*dyn| = Magnitude of Dynamic Compression 
Modulus at 0.5Hz). 
 
p<0.05 Control IL-1-stimulated 
 Eequil |E*dyn| Eequil |E*dyn| 




Interdependences among ECM components and among the measured mechanical 
properties were examined to aid in interpreting the dependences indicated by the 
regression analyses. Data from all time points were pooled for control and IL-1-
stimulated explants. Significant, negative correlations were found between percent water 
and both collagen and sGAG concentrations for both the control and IL-1 treatments 
(Table 3.2). A significant, positive correlation was found between collagen and sGAG 
concentrations for control explants but not for IL-1-stimulated explants, reflecting the 
decoupled sGAG and collagen release profiles. Significant, positive correlation 
coefficients were found among all compressive mechanical properties for both the control 
and IL-1 treatments (Table 3.3). In control and IL-1-stimulated explants, high 
correlations (0.877<R<0.929) were found between the equilibrium compressive modulus 
and the dynamic compressive modulus, suggesting that the measurements offer similar 
predictions of the mechanical integrity of the ECM.  As with the regression analyses, 
correlations are presented for the unconfined dynamic compression modulus |E*dyn| at 
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0.5Hz and the dynamic shear modulus |G*dyn| at 1.0Hz, although the reported trends were 
consistent at all other frequencies. 
3.4 Discussion 
Composition-function relationships of bovine articular cartilage were investigated 
in immature explants during IL-1-induced catabolism. These studies provide detailed 
time courses of the biochemical and biophysical changes associated with IL-1-induced 
catabolism and examine the relationships between ECM constituents and compressive 
and shear properties. The loss of ECM and compressive mechanical properties reported 
during IL-1 stimulation is consistent with previous studies using IL-121,49,53,55,93-95.  The 
compressive and shear moduli of control explants were found to be dependent on PG and 
collagen content, which is consistent with previous reports for untreated 
cartilage1,9,20,54,80,96. In contrast, IL-1 stimulation altered composition-function 
relationships, generally indicating a significant dependence of mechanical properties on 
sGAGs but not collagen. 
The composition-function relationships presented indicate a preferential 
dependence of mechanical properties on sGAG content following IL-1 stimulation, which 
may be reflective of the studies design or the degradation characteristics of the IL-1 
model. In particular, the early, rapid depletion of sGAGs following IL-1 stimulation and 
the associated decay in mechanical properties may account for the strong dependence on 
sGAG concentration, since nearly all of the decay in properties occurs prior to significant 
collagen depletion. Due to the characteristics of IL-1-induced cartilage degeneration, a 
comparable examination of the effects of depleting collagen while holding the PG content 
fairly constant is not possible with this model system. Direct enzymatic digestion of 
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collagen with collagenases has been used to investigate the specific dependence of 
mechanical properties on collagen54, but the results of this experimental system are 
difficult to interpret as passive PG release often occurs as a secondary effect of collagen 
cleavage. Recovery experiments that promote significant regeneration of collagen 
following matrix degradation could further clarify these relationships, but significant 
collagen accumulation remains a challenge in cartilage tissue engineering efforts. 
 Analysis of the temporal changes in biophysical properties following IL-1 
stimulation suggests that some measurements may be more sensitive to patterns of ECM 
loss caused by IL-1 stimulation. For the IL-1 group, Eequil reached the detection limit of 
the test at day 16 (p<0.05) while |E*dyn| and |G*dyn| were still measurable at days 24 and 
20 (p=0.052), respectively. Through day 16, sGAG and collagen content in IL-1 
stimulated explants decreased relative to controls by 96.8% and 26.2%, respectively. 
Since collagen degradation follows PG degradation in IL-1-induced cartilage 
degradation, the time course data presented here suggest that |E*dyn| and |G*dyn| may be 
sensitive to changes in collagen as well as proteoglycan content.  
While IL-1 stimulation resulted in altered composition-function relationships in 
immature articular cartilage, the reported trends may be model specific and not applicable 
to systems with different ECM composition, organization and mechanical properties. In 
particular, mature articular cartilage contains a significantly higher collagen fiber and 
collagen crosslink density9,14, lower PG content14, smaller length sGAGs5,15-17, and 
decreased cellularity97 relative to immature cartilage. Additionally, the cell-mediated 
activity of IL-1 may be more aggressive in immature than mature cartilage due to its 
higher cell density, though little age-related sensitivity to IL-1 has been reported in 
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human articular cartilage33. In addition to potential age-related differences in 
composition-function relationships, regional variations in ECM composition and 
mechanical properties have also been reported both with tissue depth28,98 and 
topographical location29,96. While the present study did not examine variations in 
composition-function relationships with topographical location, the use of immature 
middle zone cartilage minimizes variations due to tissue inhomogeneity through the 
tissue depth.    
While the correlation and regression analyses applied in the present study 
revealed differences in control and IL-1-stimulated cartilage, the study design and 
analysis should be considered when interpreting the results. Given the complex ECM 
organization and nonlinear behavior of articular cartilage, the linear regression analyses 
used here may incompletely capture the true composition-function relationships. The 
Donnan and Poisson-Boltzmann models99,100, which predict osmotic swelling pressures 
using a nonlinear dependence on PG concentration, support that argument. The 
composition-function relationships may be further influenced by the choice of 
biochemical parameters (i.e. collagen, sGAG, water). A number of other studies 
investigating composition-function relationships have evaluated collagen cleavage83 and 
pyridinoline or collagen crosslinks9,29,83,101. Collagen crosslinks and collagen cleavage, in 
particular, may be critical parameters to examine since the integrity of the collagen 
network cannot be evaluated by the hydroxyproline assay used in the present study. 
Testing mode9,29 and compressive offset20 have also been found to influence 
composition-function relationships in articular cartilage. 
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 The observed differences in composition-function relationships between control 
and IL-1-stimulated cartilage explants offer insights into the interacting contributions of 
proteoglycans and collagen to ECM function and provide a baseline for interpreting 
effects of specific interventions aimed at slowing or reversing cartilage degradation.  
Furthermore, the strong dependence of all measured physical properties on sGAG 
concentration during IL-1-induced degeneration suggests that measurements of sGAG 
concentration may be a useful surrogate for direct mechanical measurements.  For 
example, imaging techniques such as dGEMRIC (delayed gadolinium-enhanced MRI of 
cartilage)102 and EPIC-µCT103 that produce maps of tissue proteoglycan concentration 
may provide sufficient information to noninvasively estimate functional properties of 
cartilage in animal models of degeneration and recovery or in clinical practice. Through 
this and similar approaches, it may be possible to determine which matrix molecules are 
most critical to proper function or repair capacity and to lend this knowledge to future 






DEVELOPMENT AND VALIDATION OF EQUILIBRIUM 








Analysis of small animal models is limited by the availability of quantitative 
evaluation techniques for studying the ECM changes associated with OA and cartilage 
repair. Histology is traditionally used to monitor the spatial distribution of matrix 
macromolecules but is time consuming, subject to distortion artifacts and tissue damage, 
and produces only semi-quantitative analysis of 2D sections that may provide inaccurate 
3D representations. Biochemical assays are available to quantify the amount and type of 
matrix macromolecules in cartilage but these assays fail to provide their spatial 
distributions, particularly in small animals where the limited thickness and volume of 
cartilage makes it difficult or impossible to extract samples from multiple regions.  
Additionally, longitudinal monitoring of changes with time are impossible due to the 
destructive nature of these histological and biochemical techniques. 
 Proteoglycans are a particularly appropriate target for studying OA and for 
evaluating the efficacy of cartilage defect repair. PGs comprise 5-10% of articular 
cartilage by wet mass1 and are key regulators of its equilibrium and dynamic mechanical 
                                                 
 
 
1 Material presented in Chapter 4 was reprinted, with permission, from the Proceedings of the National 
Academy of Sciences 103(51):19255-19260, Palmer AW, Guldberg RE, Levenston ME, “Analysis of 
Cartilage Matrix Fixed Charge Density and Three-Dimensional Morphology Via Contrast-Enhanced 
Microcomputed Tomography”, Copyright 2006, National Academy of Sciences. 
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properties. This regulation is the result of ionic interactions between interstitial fluid and 
negatively-charged sulfated glycosaminoglycans attached to the PG backbone104. The 
amount and distribution of PGs changes substantially during development29, during 
degeneration and repair56,65, and in response to blunt trauma41. Of particular clinical 
interest, initial stages of OA are marked by aggrecanase-mediated cleavage of PGs105, 
resulting in altered sulfation patterns106 and progressive depletion of PGs from the ECM. 
Furthermore, changes in the ECM composition of articular cartilage precede and have 
been linked to changes in mechanical properties4,9. Therefore, the ability to noninvasively 
detect changes in PG content could provide an indirect indication of the integrity of the 
cartilage matrix and a means to monitor disease progression or reversal. 
 These studies address the development and validation of a contrast-based 
microcomputed tomography (µCT) technique for high resolution imaging of PGs in soft 
tissues. Microcomputed tomography is an X-ray based imaging modality capable of 
three-dimensional, quantitative morphological analysis, and current systems provide 
images at micron-level voxel resolutions. µCT imaging has traditionally been applied to 
hard tissues and is the standard for quantifying trabecular bone microstructural changes 
associated with aging and osteoporosis107,108. However, µCT has not been useful for 
direct imaging of soft tissues due to the low X-ray absorption of non-mineralized tissues.  
To compensate for the poor radiopacity of soft tissues, a novel contrast-enhanced µCT 
technique has been developed in which samples are equilibrated in a solution containing 
an ionic CT contrast agent prior to µCT scanning, yielding an equilibrium distribution of 
the ionic contrast agent that is inversely related to the density of the negatively-charged 
sGAGs. In monitoring PG content, the technique relies on detection of the Equilibrium 
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Partitioning of the Ionic Contrast agent via µCT (EPIC-µCT). The studies presented here 
used Hexabrix™ 320, a clinically available CT contrast agent containing ioxaglate, a 
negatively-charged hexa-iodinated dimer.     
To demonstrate the potential of this approach to examine the ECM of cartilage, 
data is first presented validating the ability of EPIC-µCT to monitor PG content and 
distribution in an  in vitro model of IL-1-induced cartilage degradation, a common model 
for studying cell-mediated cartilage catabolism53,93. The data indicate consistent 
agreement with traditional biochemical and histological analysis of PGs and demonstrate 
a strong correlation between X-ray attenuation and PG content. A second study presents 
data illustrating the potential of EPIC-µCT for 3D morphometric analyses of articular 
cartilage in situ on a rabbit femur. The EPIC-µCT images reproduce visible features of 
articular surface topography and ligament insertions, and segmentation of cartilage from 
the underlying bone allows quantitative analysis of cartilage morphology. 
4.2 Materials and Methods 
4.2.1 Principle of the Technique 
 Similar to the dGEMRIC technique109, EPIC-µCT relies on the partitioning of a 
charged contrast agent within a charged ECM. In cartilage, type II collagen carries a 
nearly neutral net charge while the sulfated GAGs primarily associated with the large, 
aggregating proteoglycan aggrecan confer a highly negative net charge to the ECM. The 
interstitial fluid carries a corresponding excess of positively charged solutes, resulting in 
bulk macroscopic electroneutrality.  Given these properties, conditions of electrochemical 
equilibrium predict that a negatively-charged solute capable of permeating the tissue 
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would distribute inversely to the negatively-charged sGAGs, and therefore spatially 
target regions of lower sGAG density.  For a region of tissue with a fixed charge density 
(FCD) 
m
ρ  (in Coulombs/L) submerged in a bath containing a single monovalent salt at a 
concentration 
o
C , the Gibbs-Donnan theory for an ideal solution predicts the interstitial 
anion concentration within the tissue C −  as: 
 










=               (4.1) 
     
where F  is Faraday’s constant.  For a tissue such as cartilage, a negatively-charged solute 
capable of permeating the tissue would distribute inversely to the negatively-charged 
sGAGs, and therefore spatially target regions of lower sGAG density.  If the anion 
concentration could be noninvasively detected, it would thus provide an indirect measure 
of the matrix FCD (and therefore the sGAG concentration).   
It should be noted that while Equation 4.1 describes the distribution of an ideal 
anionic solute in a dilute solution, factors including steric interactions between solutes, 
solvation effects and restricted availability of intrafibrillar water will influence the 
activity (or effective concentration) of a solute within the tissue, resulting in deviations 
from the ideal behavior.  Furthermore, most commercial contrast agents are 
multicomponent mixtures, complicating theoretical predictions of solute behavior.  
Additionally, a macroscopic imaging technique such as EPIC-µCT will actually detect 
the apparent macroscopic concentrationC − : 




where fφ  is the fluid volume fraction (approximately 0.8 for articular cartilage1).  
Consequently, the quantitative relationship between the concentration of the anionic 
contrast agent and the tissue fixed charge density will not exactly follow Equation 4.1 
and must be determined empirically for a given contrast formulation or dilution and 
tissue type.  Serial dilutions of the contrast agent (as in Figure 4.1) could then be used as 
phantoms to calibrate attenuation as a function of contrast agent concentration, allowing 
standardization of the quantification to account for different scan parameters or 




Figure 4.1: Linear decrease of X-ray attenuation with dilution of anionic CT contrast 
agents. At a given osmolality, attenuation of Hexabrix is higher than that of sodium 
diatrizoate because of the higher iodine content of the dimeric ioxaglate ion, resulting in a 
greater sensitivity to changes in matrix FCD. 
 
 
 While this approach would work in theory for any ionic contrast agent, the present 
study explored contrast-enhanced µCT imaging of cartilage using Hexabrix™ 320 
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(Mallinckrodt; Hazelwood, MO), an ionic contrast agent labeled for clinical use in 
contrast-enhanced CT scanning of the head and body and for direct injection in the 
uterus, fallopian tubes, and joint spaces. Hexabrix™ 320 is a sterile, non-pyrogenic, 
aqueous solution consisting of 39.3% (w/v) ioxaglate meglumine and 19.6% (w/v) 
ioxaglate sodium. Dissociated ioxaglate provides six iodine atoms per monovalent anion, 
resulting in a greater X-ray attenuation at a given osmolality than is achieved with tri-
iodinated monomers (Figure 4.1) and thus providing a greater sensitivity to differences in 
FCD. Considering the important functional contributions of the FCD of cartilage that 
arise from the interactions of bound sGAGs with mobile ions in the interstitial fluid, the 
osmolarity of the contrast agent was also a concern, as significant mismatches would 
yield swelling or shrinkage artifacts. While slightly hypertonic to cartilage (~300-
400mOsm/L), Hexabrix™ at 460mOsm/L represents one of the closest matches among 
ionic iodinated contrast agents. In addition, the commercial formulation of Hexabrix™ is 
pH balanced to 6-7.6pH, minimizing any concerns of the effect of short-term exposure on 
cell viability and metabolic activity.   
4.2.2 In Vitro Evaluation Model 
 To evaluate the potential for EPIC-µCT to monitor changes in the ECM of 
cartilage, degradation was produced in vitro by incubation of bovine articular cartilage 
explants with interleukin-1α (IL-1). Briefly, IL-1α and IL-1β are regulatory and 
proinflammatory cytokines implicated in the progression of OA. Within hours of 
treatment with IL-1, an upregulation in cell-mediated aggrecanase expression is noted in 
articular cartilage21,49,53. The increased aggrecanase expression leads to progressive 
degradation of the PG network. Following PG depletion, the collagen network undergoes 
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matrix metalloproteinase-mediated degradation21,49,55. Given the similarities of the IL-1 
model kinetics to matrix degradation noted during degenerative conditions, IL-1 
stimulation of articular cartilage is a well-suited model for this evaluation study. 
4.2.3 Tissue Explant Preparation and Culture 
Sixty-six 4mm diameter, full thickness explants were harvested aseptically with a 
disposable biopsy punch (Miltex; York, PA) from both stifle joints of a 2-4 week old calf 
(Research 87; Boylston, MA). Using a custom cutting block, explants were trimmed of 
all visible subchondral bone by cutting parallel to the articular surface. The tallest and 
shortest heights of each sample were measured with digital calipers and averaged to 
obtain the explant thickness. The full-thickness explants had an average thickness of 
5.00±0.07mm, with a range of 3.85-6.35mm. Sixty explants were assigned to either 
control or IL-1-treated groups and six explants were designated as Day 0 controls, with 
particular care taken to ensure a uniform distribution of thicknesses and harvest legs 
across groups. Explants were cultured in 24 well plates (Becton Dickinson; Franklin 
Lakes, NJ) in 1mL of either control medium (high glucose Dulbecco’s Modified Eagle’s 
Medium (Invitrogen; Carlsbad, CA) supplemented with 50µg/mL ascorbate (Sigma; St. 
Louis, MO), 0.1mM non-essential amino acids (Invitrogen), and 50µg/mL gentamicin 
(Invitrogen)) or control medium supplemented with 20ng/mL recombinant human IL-1α 
(Peprotech; Rocky Hill, NJ). This IL-1 concentration has previously been shown to yield 
nearly complete depletion of sGAGs from bovine articular cartilage explants within two 
weeks21. The control and IL-1-treated explants were cultured for up to 10 days, with 
media changed and collected every 48 hours. Six explants per group were removed from 
 
42 






Figure 4.2: Time course of Hexabrix equilibration in full-thickness immature bovine 




4.2.4 µCT Scanning and Analysis  
 After removal from culture, each explant was incubated with 1mL full-strength 
Hexabrix™ supplemented with protease inhibitors at 37°C under gentle agitation for 
24hrs, exceeding the time required for full equilibration (Figure 4.2). Explants were then 
patted to remove excess fluid and loaded 6 per batch into custom µCT chambers. All 
scanning was performed in air using a VivaCT 40 (Scanco Medical; Switzerland) at 
45kVa, 133mA, 200ms integration time, and a voxel size of 21µm. Though scan time 
varied with the thickness of the explant, two explants were scanned in parallel in an 
average of 15 minutes. After scanning, explants were immersed in 2mL of 0.15M PBS 
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supplemented with protease inhibitors for 24 hours at 4°C to allow for desorption of the 
Hexabrix™. One explant per condition per time point was reserved for subsequent 
histological analysis. The remaining explants were placed in fresh PBS and protease 
inhibitors and stored at -20°C until further biochemical analysis.   
 Using Scanco software, a histogram of the X-ray attenuation readings was 
generated and used to determine an appropriate threshold for image processing. The 
average X-ray attenuation was than calculated for the thresholded volume of each full-
thickness explant. To visualize the spatial variation in sGAG content, 3D color images 
representing the range of X-ray attenuation values within a sample were generated using 
Scanco image processing software. Note that valid comparisons between samples and 
accurate quantification of FCD require that consistent scan and threshold parameters be 
used for all samples and standards. 
4.2.5 Biochemical Analysis 
 Following EPIC-µCT scanning, explants reserved for biochemical analysis were 
lyophilized for 18 hours and solubilized with 1mg/mL proteinase K (EMD Biosciences; 
San Diego, CA) in 100mM ammonium acetate (pH 7.0). The digested explants and 
conditioned media were then assayed for sGAGs via the 1,9-dimethylmethylene blue 
(DMMB) colorimetric assay with shark chondroitin sulfate (Sigma; St. Louis, MO) as a 
standard90.  
4.2.6 Histology 
For comparison with the 3D spatial images generated by EPIC-µCT, a subset of 
full thickness explants was stained for sGAGs by safranin-O. Explants reserved for 
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histology were placed in 10% neutral buffered formalin for 72 hrs at 4°C before being 
transferred to 70% ethanol at 4°C until paraffin embedding and processing. Explants 
were cut down the longitudinal axis, creating two cylindrical halves. After paraffin 
embedding, 5µm-thick sections through the entire explant thickness were removed using 
a rotary microtome. Sections were stained for sGAGs using a 0.l% safranin-O solution 
with a 0.2% aqueous solution of fast green used as a counter stain. 
4.2.7 In Situ Imaging of Rabbit Femur  
 A femur was obtained post-mortem from a ~3 month old rabbit from an unrelated 
study and dissected free of surrounding tissue (Figure 4.3A). In preliminary experiments, 
the ability to visualize soft tissue during in situ imaging of an immature rabbit femur was 
highly dependent on the concentration of the Hexabrix™ equilibration solution. Use of 
the full strength Hexabrix™ solution (100%) provided excellent visualization of surface 
topology but the enhanced radiopacity of the soft tissue proved too similar to that of bone 
to allow reproducible identification of the tissue interface. As the Hexabrix™ solution 
was diluted with 0.15M PBS, the radiopacity of the soft tissue linearly decreased and the 
cartilage could be more readily distinguished from the underlying bone (Figure 4.4 inset). 
Note that dilution of the Hexabrix™ solution also decreases the sensitivity of the 
attenuation to differences in tissue FCD, and additional analyses are required to 
determine whether an intermediate contrast agent concentration will allow the cartilage to 
be distinguished from the bone while simultaneously facilitating accurate quantification 
of the FCD. Based on results of dilution studies, the femur was immersed for 1 hour in 
40/60% (v/v) Hexabrix™/0.15M PBS at 37°C under gentle agitation. The femur was 





Figure 4.3: In situ imaging of a rabbit femur via EPIC-µCT: (A) Color Photograph of a 
dissected rabbit distal femur. (B) µCT scan taken after Hexabrix desorption reveals only 
the bone geometry. (C) µCT scan taken after Hexabrix equilibration demonstrates the 
ability to visualize the articular surface. Remnants of soft tissues (black arrows) and 
scalpel cuts to the cartilage (white arrows) can be seen both in the photograph and in the 
EPIC-µCT image. (D) A thickness map generated after segmentation of soft tissue and 




appropriate threshold (Figure 4.3C). A histogram of the X-ray attenuation values 
obtained revealed two, partially overlapping peaks corresponding to contrast-enhanced 
soft tissues and calcified bone (Figure 4.4). The soft tissue peak was isolated from the 
data set using lower and upper thresholds, and a corresponding soft tissue volume was 
generated. Using a direct distance transformation algorithm (Scanco), a thickness map of 
the soft tissue volume was generated (Figure 4.3D). Following desorption of the contrast 
agent for 1 hr in 0.15M PBS, the femur was rescanned at 21µm and evaluated at the same 
threshold settings as the control image (Figure 4.3B). 
4.2.8 Statistics 
 Unless otherwise indicated, all results are reported as mean ± SEM. Minitab 
Release 12.23 (State College, PA) was used for all statistical analyses. Average X-ray 
attenuation and sGAGs released to the media with time were evaluated using a two factor 
(treatment and culture time) general linear model and using Tukey’s test (p<0.05) for 
pairwise comparisons. The relationship between explant sGAG concentration and 
average X-ray attenuation was examined via linear regression analysis. 
4.3 Results 
4.3.1 In vitro Cartilage Degeneration Model: EPIC-µCT Images   
Three-dimensional images obtained from EPIC-µCT scanning were used to 
visualize the sGAG distribution in full-thickness control and IL-1-stimulated explants 
(Figure 4.4). Consistent with the assumed inverse partitioning of the negatively-charged 
ioxaglate dimer within the ECM of cartilage, low X-ray attenuation corresponded to 
regions of high sGAG content and high X-ray attenuation indicated regions of low sGAG 
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content. Control explants showed little visible variation in X-ray attenuation with culture 
time. In contrast, increases in X-ray attenuation were apparent for IL-1-stimulated 
explants beginning at day 4. In our full thickness explant model, increases in X-ray 
attenuation appeared first in the superficial zone, deep zone and on the outer surfaces of 
the IL-1 stimulated explants and progressed towards the interior with time.  
 
Figure 4.4: Representative 3D EPIC-µCT images of control and IL-1-stimulated explants 
at 2-day intervals demonstrate progressive increases in attenuation in IL-1-stimulated 




4.3.2 In vitro Cartilage Degeneration Model: Safranin-O Histology 
Histological sections revealed similar patterns of sGAG depletion.  In longitudinal 
sections taken from the center of full-thickness explants, control explants exhibited a 
dense, uniform distribution of sGAGs (Figure 4.5). In contrast, IL-1-stimulated explants 
exhibited visible decreases in sGAG staining beginning at day 4 and continuing 
throughout the culture period. The decreased staining in the IL-1 group consistently 
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progressed from the superficial zone, deep zone and the outer surfaces inward, consistent 




Figure 4.5: Representative safranin-O-stained sections indicate a progressive loss of 
sGAG content (red staining) in IL-1-stimulated samples, consistent with the EPIC-µCT 
images. SZ denotes superficial zone (scale bar = 1mm). 
 
4.3.3 In vitro Cartilage Degeneration Model: Quantitative Changes in PG Content 
Consistent with the EPIC-µCT and histology images, the overall average X-ray 
attenuation for the full-thickness control explants did not significantly vary with culture 
time (Figure 4.6). In contrast, the attenuation of IL-1-stimulated explants progressively 
increased, with levels significantly higher than in control explants beginning at day 6. 
The increased release of PGs to the media in response to IL-1 treatment was consistent 






Figure 4.6: Average X-ray attenuation for control and IL-1-stimulated explants over 10 






Figure 4.7: sGAG release to the media for control and IL-1-stimulated explants over 10 




level of sGAGs throughout the 10 day culture (Figure 4.7). In contrast, IL-1-stimulated 
cartilage showed a characteristic rise in media sGAG levels that peaked at day 8 and was 
significantly elevated over control explants beginning at day 4. The progressive loss of 
sGAGs to the media was consistent with both reduced safranin-O staining and increased 
attenuation in EPIC-µCT analysis. 
4.3.4 Correlation of X-ray Attenuation and sGAG concentration 
 To directly examine the relationship between explant composition and X-ray 
attenuation, both control and IL-1-stimulated cartilage explants were digested and 
analyzed for sGAG content following EPIC-µCΤ scanning.   A linear regression analysis 
revealed a significant correlation (r2=0.91, p<0.0005) between X-ray attenuation and 
sGAG/H2O (Figure 4.8). The negative Pearson coefficient, r= -0.95, agreed with the 
assumed inverse distribution of a negatively charged contrast agent and sGAGs within 
the ECM. 
4.3.5 In Situ EPIC-µCT Imaging of a Rabbit Joint 
The reconstructed image of an immature rabbit femur after exposure to a 40/60% 
solution of Hexabrix™/0.15M PBS reveals articular surface topography and soft tissue 
features (Figure 4.3A and 4.3C) absent from a control image following desorption of the 
contrast agent (Figure 4.3B). In particular, the EPIC-µCT images demonstrate the ability 
to distinguish ligament insertion points (black arrows) and a scalpel registration mark in 
the articular surface (white arrow). Following segmentation of cartilage from bone using 




Figure 4.8: Inverse relationship between average X-ray attenuation and the measured 





layer (Figure 4.3D) indicates thickness values that are consistent with the anticipated 
regional variations in rabbit articular cartilage thickness.  
4.4 Discussion    
Noninvasive techniques capable of detecting PG content and distribution and 
tissue morphology could dramatically improve upon existing evaluation options for 
monitoring the efficacy of osteoarthritis treatments and cartilage repair strategies. This 
work details the development of EPIC-µCT, a novel technique for the 3D, quantitative 
imaging of PGs in soft tissues. Using IL-1 stimulation of articular cartilage as an in vitro 
degradation model, the ability of EPIC-µCT to monitor the progressive loss of sGAGs 
from cartilage explants was demonstrated. In addition, the strong correlation found 
between X-ray attenuation and sGAG density indicates that this technique can be used 
not only to monitor relative changes in sGAG content and distribution but also to 
 
 52 
quantitatively evaluate sGAG content, a feature that may prove useful for in vitro 
analysis of matrix changes in studies of tissue degeneration and development of tissue 
engineered constructs. EPIC-µCT also shows the ability to produce 3D images of the 
articular surface of cartilage in situ, illustrating potential applications in monitoring 
surface contours and engineered construct integration in defect repair studies as well as 
regional variations in cartilage thickness.  
The EPIC-µCT technique is complementary to several other methods that have 
recently been introduced. Contrast-enhanced MRI techniques including dGEMRIC have 
shown success in monitoring PG concentration in cartilage in vitro and clinically109,110, 
but the resolution of current clinical MRI systems (~300µm) and high-powered research 
MRI systems (~25µm in-plane) may limit their application in small animal models. The 
use of gadolinium-based contrast agents with µCT has also shown the potential to 
monitor PG content in cartilage explants78. OCT70 and FT-IRIS71 may also be useful in 
the noninvasive monitoring of cartilage ECM changes, potentially providing information 
on collagen and PG contents.  While the later methods provide high resolution planar 
images, quantitative analyses of 3D distributions and morphology are not currently 
possible.  Although not currently viable as a clinical imaging modality, the ability to 
simultaneously provide quantitative data regarding tissue composition and morphology 
makes EPIC-µCT a powerful new research tool. 
With the noninvasive, high resolution monitoring capability of µCT, the greatest 
benefit of this technique may lie in the assessment of ECM changes in rodent models of 
cartilage degeneration and regeneration. A promising extension of this work is the 
application of EPIC-µCT for end-stage analysis of intact cartilage surfaces after 
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dissection of small animal joints.  Furthermore, the capability of commercial µCT 
scanners for in vivo analysis raises the exciting possibility of longitudinal monitoring of 
cartilage matrix changes during disease or treatment progression in individual animals.  A 
critical step in advancing this technique is the development of accurate methodology for 
segmenting cartilage from bone in 3D data sets, as the X-ray attenuation of bone and 
Hexabrix™-equilibrated soft tissue can overlap. The overlap in X-ray attenuation is 
dependent on the mineral content of the subchondral bone as well as the FCD and water 
content of the cartilage, all of which can vary with age, health, and species. As 
demonstrated in the present study, one approach is to dilute the contrast agent sufficiently 
that the attenuation ranges of the soft tissue and bone become distinct, improving the 
delineation of the cartilage/bone interface and thus the accuracy of cartilage thickness 
measurements.  However, such dilution simultaneously reduces the sensitivity of the 
contrast agent concentration to FCD, limiting the PG monitoring capabilities of the 
technique.  If intermediate concentrations can not be identified that allow both 
morphological and compositional analysis, separate scanning after equilibration in dilute 
and concentrated contrast agent solutions may be required to fully realize the potential of 
EPIC-µCT.   Additionally, in vivo imaging raises additional technical issues involving the 
delivery and retention of a sufficient volume and concentration of the contrast agent.  
Intraarticular injection offers a simple and direct approach, although clearance of the 
contrast agent from the joint space could impair adequate equilibration. Distinguishing 
between apposed cartilage layers, underlying bone and adjacent soft tissues in a small 
animal joint will be technically challenging and may or may not be resolvable by varying 
the imaging window and the concentration of Hexabrix™ delivered.  Despite these 
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potential limitations, the present study establishes the basis for a quantitative, high 
resolution, 3D imaging technique capable of nondestructively monitoring cartilage matrix 
organization in vitro that may become a powerful tool for analyzing small animal models 
of cartilage degeneration and regeneration. 
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 CHAPTER 5 
MONITORING THE DEVELOPMENT OF TISSUE ENGINEERED 






 Tissue engineered articular cartilage represents an attractive alternative to the 
more than 475,000 total knee replacements performed annually in the United States to 
ameliorate debilitating conditions including OA111. In evaluating the success of cartilage 
tissue engineering approaches, replacement tissues are commonly benchmarked against 
the ECM composition and mechanical properties of native articular cartilage. Thus, 
significant challenges in developing an engineered cartilage tissue are characterizing 
matrix deposition and scaffold remodeling in vitro and in vivo in response to different 
biochemical and mechanical stimuli and monitoring the integration and function of the 
replacement tissue in vivo. Characterization of the ECM and mechanical properties by 
traditional methods, including biochemical colorimetric assays, histology, scanning and 
transmission electron microscopy, immunofluorescense, and mechanical testing, 
necessitate sample destruction or compromise sample sterility. Larger sample numbers 
are commonly used to compensate for destructive analysis, leading to increased study 
size and cost and the potential introduction of sample-to-sample variances. 
 To overcome the disadvantages of destructive characterization techniques, a 
number of approaches have emerged for use in the nondestructive monitoring of cellular 
and acellular tissue engineered replacements. Fluorescent labeling of cells (e.g. via Green 
Fluorescent Protein) and scaffolds has shown promise in monitoring the proliferation and 
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localization of seeded cells112,113 and scaffold degradation112,114, respectively, and the 
emergence of quantum dot technology with its superior sensitivity and specificity is 
likely to increase this approach to monitoring cell interactions in engineered tissues115. 
Similarly, 1H NMR spectroscopy has also been used in tissue engineering applications 
for monitoring cell viability in implanted agarose gel constructs116. 
 Noninvasive imaging of cartilage in particular has been the focus of several 
applications. dGEMRIC relies on the difference in T1 relaxation between control 
cartilage and cartilage equilibrated in the negatively charged contrast agent Gd-DTPA2- 
to quantify the amount and distribution of FCD109,117. dGEMRIC has demonstrated the 
ability to longitudinally monitor changes in FCD within the same sample in both 
degrading cartilage explants56 and tissue-engineered cartilage constructs68. In tissue 
engineered cartilage, dGEMRIC FCD measurements were significantly correlated with 
both equilibrium and dynamic compressive moduli but were weaker predictors of 
mechanical properties than direct biochemical measurement of FCD118. OCT and FT-
IRIS have also demonstrated recent success in monitoring matrix accumulation in 
orthopedic replacement tissues119-121. Furthermore, optical coherence elastography, a 
variant of OCT, has recently been reported to noninvasively measure mechanical strains 
in developing collagen gels122.  
 EPIC-µCT has also proven accurate in noninvasively monitoring change in sGAG 
content in articular cartilage explants103. Like dGEMRIC, EPIC-µCΤ relies on the 
exclusion of a negatively-charged contrast agent, Hexabrix™, to quantify the amount and 
distribution of sGAGs in a tissue. To that end, increases in EPIC-µCT attenuation have 
previously been shown to correspond to decreases in sGAG content in IL-1-stimulated 
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cartilage explants. The micron-level resolution, in vivo monitoring potential, unrestricted 
penetration depth, fast scan times, and sophisticated 3D morphometric analysis 
capabilities of EPIC-µCT represent a unique combination of features not readily available 
with other cartilage imaging techniques. However, the effects of the EPIC-µCT protocol, 
which includes X-ray scanning and contrast agent exposure, on matrix biochemistry 
during long-term cell culture have not been investigated. In addition, the sensitivity of the 
technique to the low levels of sGAGs found in developing matrices and its ability to 
delineate spatial patterns of matrix deposition have not been characterized. The objectives 
of this study were to characterize the effects of the EPIC-µCT protocol on sGAG 
production, cell proliferation, and cell viability in a longitudinal study of chondrocyte-
seeded agarose gels and to investigate the ability of EPIC-µCT to monitor the spatial and 
temporal development of a bilayer chondrocyte/fibrochondrocyte agarose gel. 
5.2 Materials and Methods 
5.2.1 Tissue Harvest and Cell Isolation 
 Bovine stifle joints of 1-2 week old calves were obtained within 36 hours of 
slaughter (Research 87; Boylston, MA) and dissected under aseptic conditions to expose 
the menisci and articular surface of the distal femora. Throughout the dissection, tissue 
was kept hydrated with PBS supplemented with 1X antibiotic/antimycotic (Invitrogen; 
Carlsdbad, CA). The lateral and medial menisci were removed intact from the tibial 
plateau. Using a scalpel, serial sections (~1cm2 x 1mm thick) of articular cartilage were 
removed from the femoral condyles and groove but the deep, vascularized cartilage was 
avoided. Prior to isolating cells from each tissue type, tissue samples were diced into 
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smaller sections (~1mm3) to improve the efficiency and cell viability of the isolation 
process. The pieces were added to separate T-75 flasks (Becton Dickinson; Franklin 
Lakes, NJ) containing a digestion solution consisting of DMEM, 1X 
Penicillin/Streptomycin/Neomycin, 1X Kanamycin Sulfate, 1X Fungizone (Invitrogen), 
and 0.4% type II collagenase (Sigma; Saint Louis, MO).  Digestion of the ECM was 
allowed to progress for 24-36 hours, or until the tissue was visibly digested. The digest 
solution was then strained through 37 µm nylon mesh (Small Parts; Miami Lakes, FL) 
and subjected to 1300 rpm for 7 min in an Allegra 6 Centrifuge (Beckman Coulter; 
Fullerton, CA) to isolate a cell pellet. The collagenase solution was aspirated and the cell 
pellet was resuspended in calcium and magnesium free PBS (Invitrogen). A sample of the 
cell suspension was analyzed in a Vi-CELL analyzer (Beckman Coulter) to determine the 
total cell number and number of viable cells. Cells were frozen for future use at -80°C at 
15E6 cells/mL in a solution of 10% FBS (Hyclone; Logan, UT), 10% DMSO (Fisher; 
Waltham, MA), and 80% high glucose DMEM.  
5.2.2 Gel Preparation   
 On the day of cell seeding, cells were rapidly thawed, spun down as described 
above, and the cryopreservation solution was aspirated. Cells were resuspended in 
calcium and magnesium free PBS and the cell viability was again analyzed by the Vi-
CELL analyzer.       
5.2.2.1 Homogenous Constructs 
 Articular chondrocytes (AC) were combined at 15E6 cells/mL with 3% low-
melting temperature agarose (Sigma). Gel slabs were created by sandwiching a 3mm-
thick U-shaped piece of FDA-approved rubber between glass plates and subsequently 
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allowing the agarose-AC mixture to gel in the void for 10 minutes at 4°C (Figure 5.1A). 
A 3mm diameter biopsy punch (Miltex; York, PA) was used to core out cylindrical gels, 
resulting in a final dimension of 3mm diameter x 3mm thick.      
5.2.2.2 Bilayer Constructs 
 Bilayer constructs consisted of a layer of meniscal fibrochondrocytes (MFC) and 
a layer of ACs, each seeded at 20E6 cells/mL in 3% low-melting agarose. The 
combination of MFCs and ACs were chosen to produce an inhomogeneous construct, 
given the several fold greater production of sGAGs by ACs relative to MFCs123. Gel 
slabs were formed in a two-step process (Figure 5.1A-C). First, the articular chondrocyte 
layer was formed by sandwiching a 1.5mm-thick U-shaped piece of FDA-approved 
rubber between glass plates and allowing the agarose-AC mixture to partially gel in the 
void for 5 minutes at 4°C. Next, one glass plate was carefully removed and a second 
1.5mm-thick U-shaped piece of rubber was stacked on the previous spacer. After 
replacing the glass plate, the agarose-MFC mixture was allowed to gel in the void 
between the AC layer and the glass plate for 10 minutes at 4°C. Individual gels were then 
formed using a 3mm diameter biopsy punch, resulting in a final composite dimension of 
3mm diameter x 3mm thick. 
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5.2.3 Culture Conditions and EPIC-µCT Protocol  
5.2.3.1 Homogeneous Constructs 
 To examine the repeated effects of the EPIC-µCT protocol on sGAG production, 
cell viability, and cell proliferation, fifty gels were longitudinally monitored over 24 days 
and assigned to one of five groups (n=10/group): control, Hexabrix, Scan, PBS,
 
 
Figure 5.1: Steps in Formation of Homogeneous and Bilayer Agarose Gels: (A) 
Formation of AC gel slab within U-shaped mold and, for bilayer gels, (B) addition of 







and Hexabrix+Scan. After gelation, gels were place one per well in 24 well plates 
(Becton Dickinson) in 1.0mL of control medium, which consisted of high glucose 
DMEM supplemented with 10% FBS, 50µg/mL gentamicin (Invitrogen), 0.1mM non-
essential amino acids (Invitrogen), 50µg/mL ascorbate (Sigma), and 1X 
antibiotic/antimycotic. At days 0, 8, and 16, all gels were subjected to one of five 
protocols. Gels in the control group were maintained in control medium and saw no 
additional treatment. The Hexabrix group was removed from control medium and 
maintained for 2 hours in osmotically-balanced Hexabrix (326 mOsm/kg water, as 
determined by freeze point osmometry), created by a 1:1 dilution of full strength 
Hexabrix 320 with sterile distilled water, before being returned to control medium. Gels 
in the scan group were removed from culture, blotted with a sterile tissue to remove 
surface fluid, loaded two at a time into custom cassettes (Figure 5.2), and scanned for 17 
minutes in a µCT-40 (Scanco Medical; Bassersdorf, Switzerland) before being returned 
to control medium. The PBS group was removed from culture and exposed for 2 hours to 
calcium and magnesium free PBS, then blotted and loaded two at a time in custom 
cassettes and kept at room temp for 17 minutes (to simulate the scanning time) before 
being returned to culture. Gels in the Hexabrix+Scan group were exposed to the Hexabrix 
protocol followed by the Scan protocol before being returned to culture. All gels were 
maintained at 37°C and 5%CO2 throughout the culture period, except when removed for 
scanning. Media were collected and replaced every 48 hours, with conditioned media 
from the protocol period discarded for consistency in the length of time that collected 
media were exposed to all groups. At the conclusion of the protocol on days 0, 8, and 16, 
one sample per condition was removed from culture for viability and histological 
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analysis. At day 24, one sample per condition was removed from culture for cell viability 
and histology analysis and all remaining samples were exposed to the Hexabris+Scan 
protocol to determine the endpoint EPIC-µCT attenuation. Following a 2 hour 
submersion in calcium and magnesium free PBS and protease inhibitors to allow for 
Hexabrix desorption, gels were frozen in fresh calcium and magnesium free PBS at          
-20°C until biochemical analysis.  
 
 
Figure 5.2: Schematic of custom chambers for EPIC-µCT scanning, showing close-up of 




5.2.3.2 Bilayer Constructs 
 To monitor the spatial and temporal development of heterogeneous constructs, 
forty bilayer gels were cultured for up to 48 days. After gelation, gels were place one per 
well in 24 well plates (Becton Dickinson) in 1.0mL of control medium, as previously 
described. At days 0, 8, 16, 32 and 48, eight samples were removed from culture for 
EPIC-µCT evaluation. Each sample was exposed to a 477 mOsm/kg H2O solution of 
Hexabrix, created by a 2:3 dilution with diH2O, for 2 hours at 37°C under gentle 
agitation. Agarose gels were then blotted, loaded 2 per cassette, 4 cassettes per sample 
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tube (Figure 5.2) and scanned at a 21µm voxel resolution in a µCT-40 scanner. Following 
a 2 hour submersion in calcium and magnesium free PBS and protease inhibitors to allow 
for Hexabrix desorption, gels were frozen in fresh ion-free PBS at -20°C until 
biochemical analysis. 
5.2.4 Biochemical Analysis 
 Gels were thawed at 37°C. The two layers comprising the bilayer gels were 
dissected under a magnifying glass, based on the visual difference in ECM opacity, to 
analyze each layer separately. All gels were weighed wet, lyophilized for 12 hours, and 
weighed dry. Gels were digested via a sequential proteinase K/β-agarase digestion. First, 
gels were treated with 0.2-0.4mg/mL proteinase K (Fisher) in 100mM ammonium acetate 
at 60°C for 18 hours, with periodic vortexing. Proteinase K, which also acts on β-agarase, 
was then deactivated by incubation of the samples at 100°C for 10 minutes. For agarose 
digestions, gels were first equilibrated to 45°C. Next, each gel was treated with 2U of β-
agarase for 3-4 hours at 45°C. sGAG content in the conditioned media and digests were 
analyzed on a microtiter  plate reader (PowerWave X340; Biotek; Winooski, VT) at 
525nm by the 1,9-dimethylmethylene blue assay90 using shark chondroitin sulfate 
(Sigma) as standards.  
5.2.5 Strain Analysis 
 At days 32 and 48, gels were shipped on ice in calcium and magnesium free PBS 
with protease inhibitors to the Cartilage Tissue Engineering Laboratory at the University 
of California San Diego, where the depth-dependent strain profile of four bilayer 
constructs was analyzed using the 2D microscopy technique originally developed by 
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Schinigal et al28 and refined by others98,124. Briefly, gels were exposed to a solution of 
PBS and protease inhibitors containing ethidium homodimer and calcein AM for 1hour at 
4°C to stain cell nuclei. Gels were sectioned along the longitudinal axis to produce two 
hemi-cylindrical sections. One cylindrical half was placed in a custom chamber (Figure 
5.3) A fluorescence image was taken of the sample in the uncompressed state as a 
reference image (2.9mm x 1.2mm field of view, 8-bit grayscale) for tracking the 
movement of cell nuclei. After placing the sample between two non-porous platens and 
applying a small pre-load, a 300µm (nominal 10% of gel thickness) axial compression 
step was applied at 10µm/s. After a 1 hour stress relaxation period, another image was 
acquired with the microscope. For each sample, the movements of cell nuclei from the 
reference to the compressed states were analyzed using a custom image correlation script 
developed in MATLAB 7.0 (Mathworks; Natick, Massachusetts) to determine the 
displacement field throughout the construct thickness. Lagrangian strains were calculated 
for each sample from the gradient of the measured displacement field, where w denotes 






=  5.1 
5.2.6 Cell Viability and Proliferation 
 To analyze the repeat effects of the EPIC-µCT protocol on cell viability, 
homogeneous agarose gels from each time point and condition were stained with a 
commercial fluorescent live/dead kit (Molecular Probes; Eugene, OR). Immediately after 
removal from culture, one cylindrical half of each sample was exposed to 2µM calcein 
AM and 4µM ethidium homodimer (Molecular Probes; Eugene, OR) in calcium and 
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magnesium free PBS at 37°C for 30 minutes under gentle agitation. This was followed by 
two, sequential washes in calcium and magnesium free PBS for 15 minutes each. 
Fluorescence images were obtained by dual channel excitation at 488nm and 543nm, 
with emission captured at 500-530nm and via a long pass filter at 560nm using an LSM 
510 confocal microscope (Zeiss; Germany). All images were acquired using a 10X 




Figure 5.3: Two-dimensional Strain Microscopy Setup illustrating the location of the 
agarose gel relative to the platens and epi-fluorescence microscope (left) and a 
representative image of a bilayer construct showing the stained cell nuclei (right) 
(courtesy of CTEL, UCSD). 
 
 
 As an indication of cell proliferation, all homogeneous agarose gels were exposed 
to fresh basal media supplemented with 100µL WST-1 quick cell proliferation reagent 
(Biovision; Mountain View, CA) for two hours prior to EPIC-µCT scanning on day 24. 
The media were then collected and measured at 440nm and 650nm on a multiwell 
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colorimetric plate reader. Data are reported as the difference in the readings at 440nm and 
650nm (background), normalized to a control sample of WST-1 reagent. The colorimetric 
assay measures the increase in the formation of formazan dye, which is formed as a 
byproduct of mitochondrial dehydrogenase activity.  
5.2.7 Histology 
Safranin-O was used to examine sGAG distribution by histology. After removal 
from culture, samples for histology were fixed for 12 hours at 4°C in neutral buffered 
formalin (VWR). Samples were stored at 4°C in 70% ethanol until paraffin processing 
and embedding. After paraffin embedding, 5µm-thick sections through the entire explant 
thickness were removed using a HM 355S rotary microtome (Microm; Walldorf, 
Germany). Sections were stained for sGAGs using a 0.l% safranin-O solution, for cell 
nuclei using Weigert’s Iron Hematoxylin stain, and with a 0.2% aqueous solution of fast 
green as a counter stain. 
5.2.8 Statistics 
 Minitab Release 14 (State College, PA) was used for all statistical analyses, with 
p<0.05 considered significant. Average X-ray attenuation and overall sGAG content with 
time were evaluated using a general linear model with Tukey’s test for pairwise 
comparisons. Comparisons between the EPIC-µCT treatment groups at a given time point 
were evaluated using the general linear model with Dunnett’s test for pairwise 
comparisons to the control group. Differences between AC and MFC zones at a single 
time point in the bilayer study were compared using a general linear model with Tukey’s 




5.3.1 Longitudinal Study 
5.3.1.1 EPIC-µCT Monitoring 
 To examine the ability of EPIC-µCT to monitor the progressive accumulation of 
sGAGs in engineered constructs, the Hexabrix+Scan group was followed throughout the 
24 day culture. EPIC-µCT analysis of the Hexabrix+Scan group indicated a progressive 
decrease in attenuation with time (Figure 5.4), which is indicative of an increase in sGAG 
content. This trend was also confirmed in representative EPIC-µCT images of the 
Hexabrix+Scan group cross sections (Figure 5.5), where a progressive, uniform decrease 
in attenuation was observed with time.  
 To examine the repeated effect of the EPIC-µCT protocol on matrix composition, 
gels from all conditions were analyzed by EPIC-µCT at day 24. The Hexabrix+Scan 
group measured a higher attenuation relative to the control treatment (p<0.05), but no 
other treatment group was significantly different from the control gels (Figure 5.6).      
5.3.1.2 Matrix Biochemistry Analysis 
To monitor the effect of the EPIC-µCT protocol on sGAG production and 
retention, sGAGs released to the media and accumulated in the gels were quantified. No 
differences in the cumulative amount of sGAGs released to the media were seen with 
treatment at any point during the 24 day culture (Figure 5.7). At the conclusion of the 
study, the sGAG content in each agarose gel was measured by the DMMB colorimetric 
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Figure 5.4: EPIC-µCT attenuation decreases with time in longitudinally-monitored 
homogeneous agarose gels, indicating a progressive increase in sGAG accumulation. * 





Figure 5.5: Three-Dimensional representative EPIC-µCT images of homogeneous 








Figure 5.6: EPIC-µCT attenuation for all treatment groups at Day 24. * denotes p<0.05 
versus C. C=Control, H=Hexabrix, S=Scan, P=PBS, HS=Hexabrix+Scan (n=3-6, 




Figure 5.7: Cumulative sGAG released to the media as a function of treatment and 




assay. Consistent with the EPIC-µCT attenuation findings at day 24, the Hexabrix+Scan 
group had significantly lower sGAG content relative to control gels, with no other 
significant differences from the control group (Figure 5.8). Together with the release 
data, this suggests that the cells in the Hexabrix+Scan group synthesized fewer sGAGs 
over the 24 days. Safranin-O histology sections (Figure 5.9) indicate uniform sGAG 
deposition in the interior of the constructs.  
 
Figure 5.8: Day 24 sGAG content as a function of treatment condition. * denotes p<0.05 







Figure 5.9: Safranin-O stained cross sections of day 24 homogeneous agarose gels 
illustrate the distribution of sGAGs (red) and non-sGAG-rich ECM (green). 
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5.3.1.3 Cell Viability and Proliferation    
 Cell viability and proliferation were measured to assess the potential cytotoxicity 
of the different treatments on the seeded articular chondrocytes. The WST-1 cell 
proliferation assay indicated a significant decrease in chondrocyte activity for the 
Hexabrix+Scan group relative to the control treatment (Figure 5.10). Live/Dead staining 
of constructs at day 24 were qualitatively consistent with the WST-1 results, with more 
cell death apparent in the Hexabrix+Scan group, followed by the Scan group, and the 
other treatments (Figure 5.11).    
 
 
Figure 5.10: WST-1 data for the different treatment conditions at day 24. * denotes 
p<0.05 versus Control. C=Control, H=Hexabrix, S=Scan, P=PBS, HS=Hexabrix+Scan 






Figure 5.11: Live/Dead Staining of the EPIC-µCT treatment groups at day 24, showing 
ethidium homodimer staining for dead cells (left), calcein AM staining for live cells 




5.3.2 Bilayer Study 
5.3.2.1 EPIC-µCT Attenuation Monitoring 
 EPIC-µCT analysis showed a progressive decrease in overall attenuation with 
time, indicative of an increase in sGAG content during construct development (Figure 
5.12).  EPIC-µCT images of the bilayer gels illustrate a progressive decrease in 
attenuation with time, as well as regional attenuation differences indicative of differences 
in the matrix deposition of the AC and MFC layers (Figure 5.13). As early as day 8, the 
AC layer (bottom) shows a lower attenuation (or higher sGAG content) than the MFC 
layer (top), which is consistent with the known higher sGAG synthesis rates of ACs 
relative to MFCs123 .     
 
 
Figure 5.12: Overall EPIC-µCT attenuation of bilayer constructs with time. * denotes 







Figure 5.13: Representative 3D EPIC-µCT images illustrating the developing patterns of 




5.3.2.2 Matrix Biochemistry 
 sGAG contents of the individual layers comprising the bilayer gels were analyzed 
by the DMMB assay (Figure 5.14A). Significant differences in sGAG/H2O were noted 
between layers, with the AC layers possessing significantly higher sGAG contents at 
days 8, 16, and 32. This pattern is consistent with both the EPIC-µCT images and the 
higher sGAG synthesis rate of ACs. When analyzed as total constructs, the bilayer gels 
showed a progressive increase in sGAG/H2O content with time (Figure 5.14B), or the 
expected inverse trend of the overall attenuation. Note that the volume fraction of the 
MFC layer was significantly smaller than the AC layer, resulting in an overall construct 
sGAG content that is weighted more heavily by the content of the AC layer. 
 Safranin-O staining for sGAGs supported the EPIC-µCT images and matrix 
biochemistry results (Figure 5.15). Clear delineations of the MFC layer (top) and AC 
layer (bottom) were apparent by the distribution and intensity of sGAGs. The histology 







Figure 5.14: DMMB-measured sGAG content in bilayer constructs (A) within MFC and 
AC layers and (B) over the total construct. # denotes p<0.05 between MFC and AC layer, 







Figure 5.15: Safranin-O-stained bilayer gels illustrate sGAG distribution (red) in the 




5.3.2.3 sGAG content by EPIC-µCT 
 To relate EPIC-µCT attenuation to gel sGAG content, a regression analysis 
between the overall DMMB-measured sGAG/H2O (Figure 5.14B) and the corresponding 
EPIC-µCT measurements (Figure 5.12) was performed. A significant, linear regression 
was found, indicating that gel attenuation readings were a strong predictor of sGAG 
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content (Figure 5.16). Using this calibration, EPIC-µCT attenuation measurements 
throughout the depth of the construct were converted to sGAG/H2O. The overall EPIC-
µCT sGAG measurements (Figure 5.17B) were consistent with the DMMB-based 
measurements, as expected, although the EPIC-µCT analysis predicted a higher sGAG 
content in the MFC layer (Figure 5.17A).  
 
 
Figure 5.16: Linear relationship between EPIC-µCT attenuation and sGAG/H2O in 




5.3.2.3 Strain and sGAG Inhomogeneity 
 Image analysis of the displacements of labeled cell nuclei following compression 
of the gels along the thickness provided a map of the local strain as a function of depth 
within the construct (Figure 5.18A). The data are reported as the local strain Ezz(z) 
normalized to the overall construct strain E’zz. No differences in the average strain of the 
AC and MFC layers were observed between days 32 and 48, consistent with the plateau 
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in sGAG content at the same time points. However, strains at the interface of the two gels 
appear to exhibit a smoother transition at day 48. Significant differences in strain were 
noted between the MFC layer (0-1.5mm) and AC layer (1.5-3.0mm) at days 32 and 48. 
Over days 32 and 48, the MFC layer had an average strain of 2.01 compared with 0.17 
for the AC layer, indicating the MFC layer absorbed the majority of the imposed 
deformation. 
 The local EPIC-µCT sGAG measurements also showed variation throughout the 
construct (Figure 5.18B). At day 32 in the MFC layer (subvolumes 0-12), higher sGAG 
contents were localized to the periphery of the layer. By day 48, the sGAG accumulation 
in the MFC layer was more uniform throughout its depth. In contrast, sGAG 
accumulation in the AC layer was uniform throughout its depth at both days 32 and 48. 
 
 
Figure 5.17: EPIC-µCT-measured sGAG content in bilayer constructs (A) within MFC 
and AC layers and (B) over the total construct. # denotes p<0.05 between MFC and AC 
layer, * denotes p<0.05 versus day 0, † denotes p<0.05 versus day 8, and # denotes 






Figure 5.18: Strain (A) and (B) EPIC-µCT sGAG profiles as a function of depth illustrate 






 These studies investigated the use of EPIC-µCT to longitudinally monitor 
engineered cartilage constructs and to characterize the spatial and temporal changes in 
matrix composition and mechanical properties in developing constructs. Consistent with 
previous EPIC-µCT studies103, EPIC-µCT was a strong predictor of sGAG content in 
agarose gels and exhibited sensitivity to changes in sGAG accumulation with time in 
both homogeneous and heterogeneous agarose constructs. At the intervals examined, the 
combined effects of the EPIC-µCT protocol resulted in gels with lower sGAG content, 
although Hexabrix exposure or scanning alone did not affect sGAG content. In bilayer 
agarose gels, EPIC-µCT identified an inhomogeneous sGAG distribution that indicated 
differences with zone.         
 EPIC-µCT demonstrated high sensitivity to sGAG content in agarose gels. 
Previously, EPIC-µCT had been characterized only in sGAG-rich cartilage explants and 
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joints, so the suitability of EPIC-µCT for detecting low levels of sGAG in developing 
matrices was unknown. In this study, the technique measured significant differences in 
attenuation at eight days, which represented 53.0% of the total change in attenuation over 
the culture period, and continued to measure significant decreases in attenuation through 
day 16.   
 While EPIC-µCT was sensitive to matrix accumulation in developing constructs, 
the protocol did have a significant effect on matrix production. Though there were no 
differences in the amount of sGAG released to the media among treatments, significantly 
lower sGAG was found in the Hexabrix+Scan group at day 24. The Hexabrix+Scan 
group also showed lower proliferation levels, as indicated by the WST-1 assay, and 
higher levels of cell death were present in live/dead images of the group. Given that the 
Hexabrix and Scan groups did not vary from the control treatment, the interaction of the 
Scan and Hexabrix protocols is likely responsible for the reduced matrix activity. X-ray 
exposure at the doses delivered by the Scanco CT system (~0.67Gy) has not previously 
shown significant effects on sGAG incorporation or sGAG content in 3D chondrocyte 
cultures, though decreased cell proliferation has been noted with exposure to 2Gy125. One 
potential explanation for the results is that build up of heat during X-ray scanning could 
lead to dehydration of the sample, which could be exacerbated in the presence of salts 
contained in the Hexabrix formulation. This problem could be addressed through better 
designed closed systems for housing the constructs, or if changes in temperature during 
scanning are significant, by regulating the temperature or humidity within the CT 
chamber. For in vitro studies, less frequent or fewer scanning increments are likely to 
reduce the effects of the protocol on sGAG accumulation. While the effect of the EPIC-
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µCT protocol in vivo has not been characterized, the low cytotoxicity of the Hexabrix 
formulation in vitro suggests there would be minimal effect on sGAG accumulation in 
vivo.  
 In addition to EPIC-µCT’s ability to monitor changes in sGAG accumulation in 
engineered constructs, the results of the bilayer study demonstrate the use of the 
technique to resolve spatial differences in developing constructs. For example, a subtle 
change in sGAG density at the interface of the two layers is apparent between days 32 
and 48 (Figure 5.18B). This change is reflected in the increased sGAG content in the 
MFC layer relative to the AC layer between days 32 and 48 (Figure 5.17A). Differences 
in the relative amount of sGAG in the MFC and AC zones were noted in the DMMB and 
EPIC-µCT analyses, though the techniques reported similar total sGAG content. These 
differences may reflect analysis of slightly different layer regions between the two 
techniques, due in part to variances associated with the physical dissection of the MFC 
and AC layers. To that end, EPIC-µCT’s micron-level resolution and ability to precisely 
define the analysis region may be particularly advantageous when working with small 
samples.  Furthermore, the ability to characterize spatial patterns of ECM deposition is 
critical to studies where an understanding of matrix responses to local stimuli (e.g. 
release of growth factors, degrading scaffolds) or the ability to observe matrix 
development and remodeling (e.g. stratified construct, cell co-cultures) is sought. 
 The inhomogeneous patterns of strain and sGAG content present in the bilayer 
gels suggest the importance of analyzing local composition-function relationships. 
Previous work characterizing the depth-dependent mechanical properties in stratified 
agarose layers and immature cartilage emphasized the contribution of regional 
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differences in matrix composition to the local modulus126,127. Similarly, a composition-
function analysis combining indentation measurements of tibial plateaus with site-
matched dGEMRIC measurements of sGAG content demonstrated that the Pearson 
correlation coefficient between the measured stiffness and sGAG concentration decreased 
substantially with depth, further emphasizing the significance of local changes in tissue 
composition to mechanical properties102.   
 The sensitivity of EPIC-µCT to low levels of sGAG, its ability to analyze spatial 
patterns of matrix deposition, and its potential to predict mechanical properties makes 
EPIC-µCT a power tool for investigating temporal and spatial changes in cartilaginous 
tissues. Additional work is necessary to resolve concerns with the EPIC-µCT protocol 
regarding matrix biochemistry and to fully characterize the relationships between EPIC-
µCT measurements and mechanical properties. However, the findings of this study 













CONCLUSIONS AND RECOMMENDATIONS 
 
6.1 Summary 
 The goals of this dissertation research were to investigate composition-function 
relationships in healthy, degraded, and engineered articular cartilage using EPIC-µCT 
and mechanical testing to characterize these relationships. By analyzing differences in the 
composition and distribution of ECM components and the corresponding mechanical 
properties under anabolic, catabolic, and homeostatic conditions, it may be possible to 
identify or eliminate factors (e.g. ECM content, distribution, and structure) which are 
most critical to mechanical function. This approach is particularly applicable in 
developing strategies to halt or reverse cartilage degeneration or to engineer replacement 
cartilage. In the studies presented here, ECM composition and distribution were 
significant regulators of the mechanical properties of all types of articular cartilage. In 
particular, sGAG content was a significant predictor of compressive and shear properties 
in healthy and IL-1-stimulated (degraded) cartilage, and differences in GAG content and 
distribution in engineered cartilage were reflected in its strain profile. The development 
of EPIC-µCT, with its ability to monitor sGAG content and distribution in cartilaginous 
tissues, thus provides a versatile tool for investigating composition-function relationships. 
Furthermore, the results of this work emphasize the importance of sGAG content and 
distribution in the development of therapeutic strategies for treating cartilage 
degeneration and suggest that monitoring changes in sGAG content and distribution via 
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EPIC-µCT may be an excellent indicator of the success of therapeutic strategies and a 
useful surrogate for direct mechanical assessment. 
   The studies in Chapter 3 revealed differences in the composition-function 
relationships in normal and IL-1-stimulated (degraded) cartilage explants. Consistent 
with previous studies1,9,20, the mechanical properties of healthy articular cartilage 
explants were significantly dependent on collagen and sGAG content for both 
compressive and shear moduli. sGAG content was a stronger predictor than collagen 
content of Eequil and |G*dyn|. However, collagen content was a much stronger predictor of 
|E*dyn|, indicating the importance of collagen fibers in resisting dynamic compressive 
loading18. In contrast, IL-1-stimulated explants showed no dependence on collagen 
content for compressive properties, with a weak dependence on collagen for the shear 
modulus. This finding suggests that decreases in sGAG content in articular cartilage may 
be accurate indicators of deteriorating mechanical function. Measurements of the 
mechanical properties of cartilage explants with progressive degradation also suggested 
differences in the sensitivity of the compressive and shear moduli. In IL-1-stimulated 
explants, the dynamic compressive and shear moduli were measurable at days 24 and 20, 
respectively, after nearly complete sGAG depletion but prior to significant collagen 
depletion, suggesting these measurements were sensitive to changes in both collagen and 
sGAG content. In contrast, the equilibrium modulus reached the detection limit of the 
mechanical test at day 16. Finally, the strength of the correlations between the 
equilibrium and dynamic compressive moduli (0.877<r<0.929) suggest they reflect 
similar trends in their assessment of mechanical function.  
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 The studies in Chapter 4 reported the development and validation of EPIC-µCT, a 
µCT-based tool for the assessment of cartilage composition, morphology, and function. 
Using the ionic contrast agent Hexabrix, EPIC-µCT attenuation was found to be a strong 
predictor (R2=0.91, p<0.0005) of sGAG content over a broad range of densities. EPIC-
µCT monitoring of changes in sGAG content in IL-1-stimulated cartilage explants was 
consistent with biochemical and histological assessments of sGAG content and 
distribution. IL-1 stimulation resulted in loss of sGAGs first in the deep zone of full-
thickness explants, followed by decreases in PG content throughout the explant thickness. 
In studies with a dissected rabbit femur, articular surface morphology (e.g. scalpel cuts, 
ligaments) was visible with EPIC-µCT that was not visible with conventional µCT. 
Analytical methods were also developed to segment cartilage from other tissues and 
measure its thickness, highlighting EPIC-µCT’s ability to provide information on sGAG 
content as well as cartilage morphology.      
 The studies in Chapter 5 examined the potential of EPIC-µCT to monitor the 
development of engineered cartilage. The effects of the EPIC-µCT protocol on sGAG 
production were examined. Over a 24 day culture with 4 equally-spaced evaluations 
using EPIC-µCT, significant decreases in sGAG accumulation and mitochondrial activity 
and high levels of cell death were noted in the Hexabrix+Scan group. Effects on sGAG 
accumulation and cell proliferation and viability were not noted with the Hexabrix only 
and Scan only treatments, indicating that the results may represent an interactive effect. 
Dehydration from elevated temperatures during scanning may account for the noted 
differences, but additional characterization is needed. In studies using bilayer agarose 
gels, differences in sGAG deposition in the distinct layers were detected using 
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biochemical analysis, histological assessment, and EPIC-µCT. Higher levels of sGAG 
content were found in the AC layer, consistent with the higher rate of sGAG 
incorporation reported for ACs over MFCs123. The patterns of sGAG accumulation 
resulted in an inhomogeneous profile through the thickness of the construct. Strain 
microscopy analysis through the construct depth indicated significantly lower strains 
were localized in the AC layer than the MFC layer, indicating the AC layer was much 
stiffer. The higher level of sGAG content in the AC layer and the greater stiffness of the 
AC layer suggested by the strain analysis indicate the importance of sGAG content and 
distribution in the mechanical properties of engineered cartilage. 
6.2 Conclusions 
 One of the most significant findings of this work relates to the versatility of EPIC-
µCT. In studies with cartilage explants and engineered cartilage, EPIC-µCT was accurate 
over a broad range of sGAG/H2O (~5-70mg/mL) and sensitive to low levels of sGAG 
accumulation in agarose gels (~17µg/mg wet weight). In addition, EPIC-µCT images also 
revealed soft tissue morphology (e.g. articular surface cuts, ligaments) not visible with 
traditional µCT. The analytical capabilities of µCT also allowed for the segmentation or 
isolation of articular cartilage from other tissues in situ in a rabbit joint and the spatial 
assessment of inhomogeneous sGAG content in engineered cartilage. Furthermore, the 
results of the EPIC-µCT-estimated sGAG measurements and strain analysis of the AC 
and MFC layers in Chapter 5 together suggest that EPIC-µCT sGAG measurements may 
also be predictive of mechanical function in engineered cartilage. 
 EPIC-µCT and dGEMRIC have been shown to be excellent predictors of sGAG 
content in healthy, degraded, and engineered cartilage and have also demonstrated the 
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ability to quantify the distribution of sGAG content. The later capability is especially 
critical for monitoring the local effects of tissue engineering and other interventional 
strategies. As demonstrated in chapter 5, this approach can illustrate regional differences 
in sGAG accumulation during development of stratified tissue engineered constructs. In 
addition, these techniques may prove useful in monitoring the integration and maturation 
of constructs in cartilage defect repair models. µCT has previously been used to 
characterize the porosity and anisotropy of polymer scaffolds128, suggesting the use of 
EPIC-µCT to simultaneously monitor both the remodeling of tissue engineering scaffolds 
and the matrix accumulation within the constructs. EPIC-µCT’s ability to segment 
materials of differing radiopacity for analysis epitomizes its versatility and analytical 
power. Furthermore, EPIC-µCT may also be useful in monitoring the effects of local 
therapies (e.g. growth factors, gene delivery, drug treatments) on sGAG composition in 
adjacent orthopedic soft tissues in vivo. Though the ability to noninvasively visualize soft 
tissues is not unique to EPIC-µCT, its ability to isolate and quantify regional differences 
in sGAG composition and tissue morphology encourages its use in a number of 
applications.   
 Analysis of composition-function relationships underscores the importance of 
bulk ECM content to the mechanical properties of cartilaginous tissues, but the 
contributions of ECM distribution and organization should not be overlooked in assessing 
cartilage function. The challenge lies in isolating the roles of ECM molecules in a tissue 
like cartilage which exhibits both macroscopic inhomogeneity and anisotropy. The 
composition-function analyses in Chapter 3 were performed on middle zone cartilage, 
which while relatively uniform in composition (Figure 2.3), still exhibits anisotropy, 
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primarily due to the orientation of collagen fibers. In those studies with degraded 
cartilage, collagen content was not a significant predictor of compressive properties yet 
sGAG content alone could not completely account for the measured properties. This 
observation suggests the role of additional parameters other than bulk ECM content in 
regulating cartilage mechanical properties. This argument is supported by composition-
function analyses of enzymatically-degraded, full-thickness cartilage explants, which 
indicated that spatial or zonal differences related to the inhomogeneity of the cartilage 
ECM and the anisotropy of its structure were significant predictors of the Young’s 
modulus54. In addition, increases in pyridinoline crosslinks with maturation were 
significant predictors of increases in tensile moduli strength in bovine cartilage 
explants29, indicating that the structural organization of collagen fiber bundles also 
regulates the mechanical properties. Changes to the collagen fiber birefringence in the 
superficial zone have also been noted prior to macroscopic ECM changes in experimental 
OA models18,129, adding further evidence that bulk mechanical properties (and sGAG, in 
particular) may not provide the earliest indication of degeneration or fully predict 
mechanical function. As previously stated, it is difficult to isolate the effects of bulk 
ECM content from the role of cartilage inhomogeneity and anisotropy, but these factors 
should be considered when using bulk sGAG-based diagnostics, such as EPIC-µCT and 
dGEMRIC, in monitoring cartilage degeneration or assessing mechanical function. 
 In evaluating the success of interventional strategies aimed at reversing 
degeneration and engineering strategies aimed at developing replacement cartilage, 
comparisons are often made to the composition and mechanical properties of the native 
tissue. Composition-function analyses support these comparisons by emphasizing the 
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importance of ECM components, particularly sGAG and collagen, to articular cartilage 
mechanics. An important observation that has been given more recent attention in the 
tissue engineering community is that the exact composition of native cartilage may not be 
necessary to achieve equivalent mechanical function. This is evident in a study 
examining the recovery of sGAG content and mechanical properties in cartilage explants 
following a brief period of IL-1-induced catabolism, where compressive moduli 
recovered to control levels despite significantly lower levels of sGAG content in IL-1-
stimulated explants130. This finding suggests the importance of other factors (e.g. ECM 
distribution and organization) in regulating mechanical properties and implies that 
targeting native levels of ECM composition may not be necessary or even worthwhile 
given the remodeling that will occur in vivo. 
 Given the limited success of clinical regenerative therapies, preservation of 
existing cartilage function by protecting the ECM may be the best strategy for managing 
degeneration in the short term. The importance of sGAG content in the loss of 
mechanical properties in IL-1-stimulated cartilage suggests it may be an appropriate 
target for interventional strategies. To that end, Pratta et al. have suggested that the PG 
aggrecan may afford protection to the collagen network in articular cartilage, as 
evidenced by the preservation of collagen content when IL-1-stimulated articular 
cartilage was treated with an aggrecanase inhibitor89. This protection however appears to 
be transient, only delaying depletion of the ECM and the loss of mechanical properties95. 
These and other studies indicate that the ECM may be degraded by a combination of 
MMPs, aggrecanases, and other enzymes. Thus, until the mechanisms responsible for 
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ECM degradation are identified, it will be difficult to prevent degeneration despite 
improved understandings of composition-function relationships.    
6.3 Future Recommendations 
 This dissertation research reinforced the importance of sGAG content to the 
mechanical properties of healthy, degrading, and engineered cartilage and introduced 
EPIC-µCT as a powerful technique for the assessment of changes in PG content and 
morphology in vitro and in situ. The most obvious extensions of this work are in the 
continued development and application of EPIC-µCT. There are a number of possible 
areas of research related to studying the progression of OA, evaluating the success of 
tissue engineering strategies, investigating more basic cartilage mechanics problems, and 
potentially, developing EPIC-µCT as a clinical diagnostic. 
 EPIC-µCT is a particularly attractive technique for assessing composition and 
morphology changes in small animal models of degeneration and regeneration. In 
rodents, in particular, the articular cartilage is on the order of 100µm at its thickness 
point, making assessment of changes in sGAG content difficult with the spatial resolution 
currently offered by existing techniques (e.g. dGEMRIC). As outlined in Chapter 4, a 
number of technical hurdles must be addressed to realize in vivo potential in small 
animals. Briefly, these include experimental validation of the in situ thickness 
measurements presented in Chapter 4, determining optimal Hexabrix dilution for sGAG 
and thickness measurements, evaluating Hexabrix delivery options (e.g. systemic versus 
intraarticular injection), and characterizing the optimal scanning window. 
 A number of opportunities to apply EPIC-µCT also exist in the tissue engineering 
community. The results of Chapter 5 suggest that additional evaluation is needed to use 
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EPIC-µCT in the longitudinal monitoring of tissue engineered constructs in vitro. It may 
also be of interest to use the technique in characterizing the development of 
osteochondral constructs in vitro and their subsequent integration following implantation 
in vivo. The ability to characterize both cartilage composition and bone architecture 
would make excellent use of the powerful analytical capabilities of EPIC-µCT. 
 EPIC-µCT may also be of interest in studies related to basic cartilage mechanics. 
Work presented in Appendix A outlines the development of a micro indentation device 
that allows for the controlled compression of cartilaginous tissues and subsequent EPIC-
µCT analysis of changes in matrix composition and structure. This system, with the 
inclusion of a load cell, can be used to monitor stress relaxation of tissues. It may be 
useful to studies investigating the effects of compression on changes in local FCD and 





DEVELOPMENT OF AN EPIC-MICROCOMPUTED 
TOMOGRAPHY-COMPATIBLE MICROINDENTATION DEVICE 
AND PRELIMINARY CHARACTERIZATIONS OF 





 Physiologic loading of joints deforms the 3D structure of articular cartilage, 
resulting in complex changes in the local strain field and the inhomogeneous FCD. 
Changes in the mechanical environment induced by mechanical loading have previously 
been reported to regulate cell matrix synthesis123,131,132. In addition, local changes in the 
FCD and strain field due to applied deformations are germane to accurate design and 
interpretation of indentation measurements of articular cartilage stiffness88,124 and to the 
development of accurate models relating tissue composition to mechanical properties. 
Characterizing these changes has proven challenging due to the need to analyze changes 
in ECM distribution and local deformation in the deformed state. 2D video microscopy 
techniques capable of measuring the continuous depth-dependent strain and FCD of full-
thickness articular cartilage explants have increased our understanding of these changes 
28,133. However, a technique capable of 3D mapping is necessary to fully characterize 
changes in FCD and deformation. EPIC-µCT, a contrast-enhanced microcomputed 
tomography technique that has been used to quantitatively monitor in vitro FCD 
decreases during cartilage degeneration103 and FCD increases during development of 
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engineered cartilage, represents a viable alternative to existing approaches with its high 
resolution, 3D assessment capabilities.  
 This work was initiated to explore the use of EPIC-µCT to monitor changes in 
FCD and local deformation due to compression. Initial work focused on the development 
and validation of an EPIC-µCT-compatible microindentation device to apply controlled 
deformations. Subsequent work focused on characterizing compression-induced changes 
in FCD in full-thickness articular cartilage explants and in visualizing changes in 
deformation due to indentation. While proof of principle was established, difficulty was 
encountered when trying to characterize the time necessary to reach contrast agent 
chemical equilibrium following compression. Additional characterization of the system is 
necessary to resolve this issue. 
A.2 Development and Validation of the Microindentation Device 
A.2.1 Design Considerations 
 There were a number of design constraints, imposed primarily by the EPIC-µCT 
protocol and the µCT scanner. First, the EPIC-µCT protocol necessitated that the device 
include a well around the sample to be filled with Hexabrix during chemical 
equilibration, both before and after compression. Since the samples in the EPIC-µCT 
protocol (Appendix B) are scanned in air rather than liquid, it was also necessary to be 
able to drain the Hexabrix from the device and to have access to the free surfaces of the 
sample to blot surface fluid that would produce scanning artifacts. In addition, materials 
used in constructing the device could not interfere with the X-ray signal (i.e. the materials 
needed to be of low radiopacity). The device also needed to include a calibrated, 
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controlled system for applying uniaxial compression. To ensure the versatility of the 
device for characterization of a wide range of sample geometries, the device also needed 
to accommodate samples with thicknesses ranging from 2mm to 6mm. Finally, to 
facilitate imaging at a spatial resolution of 21µm, the device needed to fit within a space 
of 20mm diameter by 80mm. 
A.2.2 First Generation Microindentation Device 
 The frame of the microindentation device consists of two delrin platforms 
connected by two threaded delrin rods (Figure A.1A). The rods allow for gross 
positioning of the platforms to account for a range of sample thicknesses. A digital 
micrometer is used in positioning the platforms to ensure that they are parallel. A rotating 
spindle micrometer head (Mitutoyo Model 148-203) with a range of 0-6.5mm is secured 
to the top platform by a lock nut. A micrometer head with a non-rotating spindle with this 
range and meeting the size constraints of the µCT chamber could not be located, so a 
coupler was designed to absorb the rotation of the micrometer spindle while delivering 
the intended axial translation. This coupler, also made of delrin, was machined to include 
the 4mm diameter flat indentor at its base (Figure A.1B). A 0.25in diameter hole bored 
into the top of the coupler held a stainless steel ball bearing (OD 0.25in, ID 0.125in) that 
was press fit into the bore space. The 0.125in diameter spindle shaft of the micrometer 
head was press fit into the ball bearing. Rotation of the coupler assembler was prevented 
by fixing it via two 1mm diameter stainless steel shafts to the top platform. The collective 
design of the coupler assembly transferred all of the spindle rotation to the ball bearings 
but permitted uniaxial translation of the indentor. The outer diameter of the bottom 
platform was externally threaded to mate with a threaded cylindrical shell, forming a well 
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to hydrate the sample. A keyed post was fixed to the bottom platform for interfacing the 





Figure A.1: Color photographs of the first generation microindentation device depicting 




A.2.3 Second Generation Microindentation Device 
 A load cell was incorporated into a second version of the device in order to 
measure the resultant stress arising from compression (Figure A.2). The load cell was 
required to have a diameter less than 10mm and an interface that could be modified to 
serve as an 8mm diameter rigid, flat platen. A 10lb male threaded load button (Futek 
Model LLB 210) met these requirements, and an 8mm diameter flat stainless steel platen 
was machined to interface with the threaded rod of the load button. The bottom platform 




Figure A.2: Color photographs of the second generation microindentation device showing 
the (A) assembled device and (B) the cylindrical shell removed to expose the load cell 
button in the bottom platen. 
 
 
Briefly, the bottom was machined as two pieces. A bore was drilled through the top half 
of the new bottom platform to accommodate the diameter of the load cell and button. The 
load cell was sandwiched between the two halves, which were secured together by delrin 
screws. The load cell cable exited via a channel cut along the outer diameter of the 
bottom platform, preventing any interference with the X-ray detector as the device was 
moved along the cylindrical bore of the scanner. A disconnect attachment was wired to 
the cable, allowing the cable to be separated from the data acquisition system during 
scanning. The signal of the load cell was amplified by a custom amplifier with a 1000X 
gain, which was connected to a data acquisition card (National Instruments PCI-6229) 
and a local PC. Data acquisition was performed using LabView 7.1. Unfortunately, the 
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load cell was damaged after testing of initial samples, preventing complete validation of 
the design.  
A.2.4 Validation of Applied Uniaxial Compression  
 To determine the differences between the requested compressive displacement 
and the displacement felt by the sample, the translation of the system was characterized. 
The system was characterized using a LX300 laser micrometer with a 1µm resolution, 
with data acquired using TestWorks software (MTS; Eden Prairie, MN). The laser 
micrometer works by tracking motion of markings on reflective tape relative to a fixed 
point of reference. In this setup (Figure A.3), reflective tape was placed on the moving 
top platen and the base of the microindentation device. The micrometer head was 
translated approximately 100µm (rotated approximately 72°), as indicated by its 10µm 





Figure A.3: Color photographs of the validation experiment showing (A) close up of laser 
beam spanning reflective tape (black arrows) and (B) overview of laser micrometer 

















































A.3 Preliminary Characterization of Changes in FCD and Deformation with 
Uniaxial Compression 
                                                           
A.3.1 Methods 
A.3.1.1 Sample Preparation  
 Four 4mm diameter and one 8mm diameter, full thickness cartilage explants were 
harvested aseptically from the femoral condyles and femoral groove of a 1-2 week old 
calf. The samples were trimmed of any visible subchondral bone using a custom cutting 





A.3.1.2 EPIC-µCT Scanning 
 After thawing, each explant was allowed to equilibrate in full strength Hexabrix™ 
(Mallinckrodt) for 24 hours at 37°C under gentle agitation. Prior to scanning, each 
sample was blotted to remove excess surface fluid. All samples were scanned in air at a 
21µm voxel resolution in a Scanco VivaCT 40. Between scans, the well formed by the 
base of the indentation device and a removable cylindrical shell was filled with 
Hexabrix™, the opening was sealed with parafilm, and the device was maintained at 
37°C.       
A.3.1.3 Unconfined Compression and Indentation  
 A custom, EPIC-µCT-compatible microindentation device with a 4mm diameter  
flat, impermeable platen (Figure A.1) was used to apply axial compressive strains to full-
thickness explants. For unconfined compression experiments, the platen was lowered 
until contact was made with the articular surface. This position represents the 
uncompressed sample. The sample was subsequently compressed by 10% and 20% of the 
uncompressed height at ~10µm/s with a 2hr relaxation period between each step. EPIC-
µCT scans were made of the uncompressed state and at each compression level.  
A.3.2 Results 
 Using the EPIC-µCT calibration curve previously determined for articular 
cartilage (Figure 4.8), EPIC-µCT attenuation measurements as a function of depth were 
converted to sGAG/H2O and then to FCD (mEq/mL), assuming all sGAGs were 
chondroitin sulfate with a molecular weight of 458 g/mol. Consistent with reported 
values133, the EPIC-µCT-estimated FCD of uncompressed explants ranged from a 
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minimum of 0.065 mEq/mL in the most superficial 10% of the explant thickness to a 
maximum of  0.19 mEq/mL in the deepest zone (Figure A.11). To analyze differences in 
the effects of compression on EPIC-µCT-estimated FCD as a function of depth, the 
average EPIC-µCT-estimated FCD at each subvolume was normalized to the maximum 
value measured in the explant. Unconfined axial compression increased the EPIC-µCT-
estimated FCD of the explants, with the greatest increase appearing during the 10% 
relaxation step and in the superficial zone, where the greatest local strain would be 
expected (Figure A.12). The increase in EPIC-µCT-estimated FCD in the superficial zone 
as well as the compaction of the superficial zone was also apparent in longitudinal slices 
taken from the center of a representative explant (Figure A.13). Analysis of the non-
normalized EPIC-µCT-estimated FCD (not shown) indicated no significant increase in 
FCD for the entire explant, suggesting that chemical equilibration of Hexabrix following 
compression might be incomplete. 
 EPIC-µCT images of a 4mm flat indentor pre and post 10% compression of an 
8mm diameter sample identified the deformation pattern in the cartilage samples (Figure 
A.14). The sharp edges of the indentor geometry were clear visible, as were complex 






Figure A.11: EPIC-µCT measurements of FCD as a function of depth in uncompressed 







Figure A.12: EPIC-µCT measurements of normalized FCD illustrate zonal differences in 









Figure A.13: EPIC-µCT images of the FCD of a representative sample indicate local 





Figure A.14: EPIC-µCT images of an 8mm full-thickness cartilage explant before (left) 
and after (right) 10% compression by a 4mm flat indentor. The arrows indicate the 









A.4 Characterization of Chemical Equilibrium 
A.4.1 Introduction 
Before proceeding with additional studies, it was necessary to characterize the 
time needed for the contrast agent to reach chemical equilibrium. This is a legitimate 
concern with articular cartilage, where static compression has been shown to reduce 
tissue permeability and increase diffusion time of solutes134. Given that 18 hours was 
needed to reach chemical equilibrium in full thickness articular cartilage explants (Figure 
4.2), it may require more than the 2 hours given in the preliminary study to again reach 
equilibrium, despite the much shorter re-equilibration anticipated in the redistribution of 
Hexabrix™ following a 10% compression step.    
A.4.2 Chemical Equilibration  
The goal of this experiment was to characterize the amount of time required to 
reach chemical equilibrium for an explant following 10% uniaxial static compression. 
Full-thickness articular cartilage explants were harvested from the femoral condyles of 1-
2 week old femurs, trimmed of subchondral bone, and frozen at -20°C in PBS with 
protease inhibitors until the day of testing. After thawing at 37°C, the sample was 
equilibrated for 24 hours at 37°C under gentle agitation in full-strength Hexabrix 
supplemented with protease inhibitors. The sample was then blotted and scanned at its 
uncompressed state in a µCT 40 (Scanco). After scanning, the indentation device was 
filled with Hexabrix™ and the sample was compressed by 10% of its height. The sample 
was allowed to relax in its compressed state at 37°C. At periodic intervals (2, 4, and 19 
hours), the device was drained of Hexabrix, the sample was blotted, and the samples was 
imaged by EPIC-µCT. Attenuation measurements were converted to FCD (mEq/mL) as 
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previously described. With time, samples showed either no change or decreases in EPIC-
µCT-estimated FCD (Figure A.15), which contradicts conventional theory.    
 
 
Figure A.15: Changes in FCD with compression state and equilibration time for full 





A.4.3 Active Exudation of sGAGs  
 One potential explanation for the observed decreases in FCD during chemical 
equilibrium was stress-induced exudation of sGAGs from the ECM due to the applied 
deformation. To test this theory, untested samples were placed in the indentation device 
with 1.5mL PBS and compressed by 10% of their sample height. The PBS was collected 
and replaced at periodic intervals (1, 2, 3, and 4 hours post-compression). A subset of 
samples (Samples 1 and 2) were unloaded at the end of 4 hours, allowed to recover to 
their original height over 1 hour in PBS, and recompressed to 10% thickness. PBS 
collections were made at 1 and 2 hours post-recompression (1r, 2r) to see if a second 
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compression would exude sGAGs disrupted by the initial compression. The PBS 
collections were subsequently analyzed for sGAG content by the DMMB assay. Note that 
Hexabrix was not used for these experiments as it might interfere with the DMMB assay, 
which relies on the ionic binding of the dye with negatively-charged species (i.e. 
Hexabrix and sGAGs). The results of this study, presented in Figure A.16, indicate that 
~16µg of sGAGs per explant were released over the 4 hours post-compression and that 





Figure A.16: sGAG released during a 10% static compression as a function of time. 1r 





 After being unable to reach chemical equilibrium over a 19 hour period, which 
was previously sufficient for uncompressed explants, and being unable to account for the 
observed decreases in EPIC-µCT-estimated FCD, these studies were halted. One possible 
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explanation that may account for the noted decrease in EPIC-µCT-estimated FCD is 
explant swelling, which could result in an effective dilution of the EPIC-µCT-estimated 
FCD. Cartilage explants in culture are known to swell with time, due in part to decreased 
ability of cut collagen fibers at the free surface of the explants to prevent swelling of the 
entrapped PGs. Theoretical calculations of the amount of water needed to dilute the FCD 
of an explant of this geometry suggest it would be on the order of 10µL, which would be 
difficult to measure experimentally. If it is not possible to resolve this issue, this approach 
to characterizing deformation-induced changes in EPIC-µCT-estimated FCD may still be 










EPIC-MICROCOMPUTED TOMOGRAPHY PROTOCOL 
 
 
B.1 Hexabrix Equilibration and Sample Preparation 
 This protocol is appropriate for bovine cartilage explants up to 4mm diameter and 
6 mm thick and for agarose gels up to 3mm diameter and 3mm thick. The Hexabrix 
equilibration time should be increased for larger diameter and thicker samples, and the 
design of larger sample cassettes may be necessary. NOTE: Hexabrix is light sensitive 
and should be stored appropriately. 
 
1. The experiment should be timed such that scanning is performed immediately after 
sample equilibration is complete. 
 
2. Equilibrate 1 explant in 1mL of full strength Hexabrix 320 (Mallinckrodt) for 24 hours 
or 1 agarose gel in 1mL of a solution of 1:1 Hexabrix 320:diH2O for 2 hours in a sealed 
microcentrifuge tube at 37°C under gentle agitation using a shaker plate. 
 
3. Remove the sample from Hexabrix and blot surface fluid using a KimWipe.  
 
4. Using tweezers or a “scoop”, carefully place the sample in a well of the custom CT 
cassette. Stretch parafilm over the cassette to seal the well and prevent sample 
dehydration. Place the cassette into the sample tube, pushing it to the bottom of the tube. 




5. Secure sample tube in CT chamber and initiate scanning. The scan and evaluation 
parameters of B.2 should serve as a guide.    
B.2 CT Scan and Evaluation Parameters 
B.2.1 CT Settings 
B.2.1.1 VIVA CT 
 
Table B.1: VIVA CT Settings for EPIC-µCT 
Parameter Value 
Current 133 µA 
Voltage 45 kVp 
Integration Time 200ms 
Voxel Size/Sample Tube Diameter 20.5µm nominal (adjust as appropriate) 




B.2.1.2 µCT 40 
 
Table B.2: µCT 40 Settings for EPIC-µCT 
Parameter Value 
Current 177 µA 
Voltage 45 kVp 
Integration Time 200ms 
Voxel Size/Sample Tube Diameter 20.5µm nominal (adjust as appropriate) 










B.2.2 Evaluation Settings 
 
 
Table B.3: 3D Evaluation settings for the experiments presented in chapters 4 and 5. 
NOTE: The choice of threshold will change with the strength of Hexabrix used. 
  
Parameter Cartilage 3% Agarose 
Sigma 1.2 1.2 
Support 2 2 
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